2024

Harrison, L. L., Fu, E. L., Thomson, P. C., Traynor, J. P., Mark, P. B. and Stoumpos, S. (2024) Impact of arteriovenous fistula formation on trajectory of kidney function decline: a target trial emulation. Clinical Kidney Journal, (Accepted for Publication)

Lambourg, E. J. et al. (2024) Stopping versus continuing metformin in patients with advanced CKD: A nationwide Scottish target trial emulation study. American Journal of Kidney Diseases, (doi: 10.1053/j.ajkd.2024.08.012) (PMID:39521399) (In Press)

Rochmawati, I. D., Deo, S. , Lees, J. S. , Mark, P. B. , Sattar, N. , Celis-Morales, C. , Pell, J. P. , Welsh, P. and Ho, F. K. (2024) Adding traditional and emerging biomarkers for risk assessment in secondary prevention: a prospective cohort study of 20,656 patients with cardiovascular disease. European Journal of Preventive Cardiology, (doi: 10.1093/eurjpc/zwae352) (PMID:39474888) (Early Online Publication)

Walker, H., Sullivan, M. K. , Jani, B. D. , Mark, P. B. and Gallacher, K. I. (2024) Exploration of patients’ and health care professionals’ perspectives of kidney failure risk and the use of the kidney failure risk equation in MULTIPle lOng-term condItions aNd frailTy (MULTIPOINT) study: a qualitative interview and focus group study protocol. BMJ Open, 14(10), e085843. (doi: 10.1136/bmjopen-2024-085843) (PMID:39424379)

Walker, H., Day, S., Grant, C. H. , Jones, C., Ker, R., Sullivan, M. K. , Jani, B. D. , Gallacher, K. and Mark, P. B. (2024) Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review. BMC Medicine, 22, 452. (doi: 10.1186/s12916-024-03649-9) (PMID:39394084) (PMCID:PMC11470573)

Liu, Q., Celis-Morales, C. , Lees, J. S. , Sattar, N. , Ho, F., Pell, J. P. , Mark, P. B. and Welsh, P. (2024) Change in physical activity and its association with decline in kidney function: A UK Biobank-based cohort study. Journal of Cachexia, Sarcopenia and Muscle, 15(5), pp. 2046-2055. (doi: 10.1002/jcsm.13551) (PMID:39155482) (PMCID:PMC11446710)

Marshall, W. R., Curran, G. A., Traynor, J. P., Gillis, K. A. , Mark, P. B. and Lees, J. S. (2024) Sodium zirconium cyclosilicate treatment and rates of emergency interventions for hyperkalaemia: a propensity-score weighted case-control study. Clinical Kidney Journal, (doi: 10.1093/ckj/sfae313) (Accepted for Publication)

Elyan, B. M.P. , Sullivan, M. K. , Hedley, J., De La Mata, N., Webster, A. C., Venugopal, B., Jones, R. J. , Lang, N. N. , Mark, P. B. and Lees, J. S. (2024) The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis. BJC Reports, 2, 57. (doi: 10.1038/s44276-024-00081-7)

Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)

Lam, C. S.P. et al. (2024) Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial. European Journal of Heart Failure, 26(8), pp. 1727-1735. (doi: 10.1002/ejhf.3294) (PMID:38783712)

Madero, M., Chertow, G. M. and Mark, P. B. (2024) SGLT2 inhibitor use in chronic kidney disease: supporting cardiovascular, kidney, and metabolic health. Kidney Medicine, 6(8), 100851. (doi: 10.1016/j.xkme.2024.100851)

Sullivan, M. K. , Lees, J. S. , Rosales, B. M., Cutting, R., Wyld, M. L., Woodward, M., Webster, A. C., Mark, P. B. and De La Mata, N. (2024) Sex and the relationship between cardiometabolic risk factors and estimated GFR Decline: a population-based cohort study. American Journal of Kidney Diseases, (doi: 10.1053/j.ajkd.2024.05.007) (PMID:39053834) (In Press)

Collister, D. et al. (2024) Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae156) (Early Online Publication)

Zac-Varghese, S. et al. (2024) Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024. BMC Nephrology, 25(1), 216. (doi: 10.1186/s12882-024-03664-1) (PMID:38971750) (PMCID:PMC11227212)

Denicolò, S. et al. (2024) Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus. Diabetologia, 67(7), pp. 1283-1294. (doi: 10.1007/s00125-024-06149-w) (PMID:38647650) (PMCID:PMC11153278)

Denicolò, S. et al. (2024) Non-adherence to antidiabetic and cardiovascular medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus. Diabetologia, 67(7), pp. 1283-1294. (doi: 10.1007/s00125-024-06149-w) (PMID:38647650) (PMCID:PMC11153278)

Chertow, G. M. et al. (2024) Effects of dapagliflozin in patients with membranous nephropathy. Glomerular Diseases, 4(1), pp. 137-145. (doi: 10.1159/000539770) (PMID:39144475) (PMCID:PMC11324228)

Curtain, J. P. et al. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, 26(6), pp. 1383-1392. (doi: 10.1002/ejhf.3290) (PMID:38741283)

Loughrey, C. et al. (2024) A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic action: Pre-clinical and phase I study. British Journal of Pharmacology, 181(18), pp. 3401-3419. (doi: 10.1111/bph.16379) (PMID:38773354)

Stoumpos, S., van Rhijn, P., Mangion, K., Thomson, P. C. and Mark, P. B. (2024) Arteriovenous fistula for haemodialysis as a predictor of de novo heart failure in kidney transplant recipients. Clinical Kidney Journal, 17(5), sfae105. (doi: 10.1093/ckj/sfae105) (PMID:38737344) (PMCID:PMC11087827)

Del Vecchio, L. et al. (2024) Iron biology. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae095) (PMID:38658189) (Early Online Publication)

Rankin, S., Elyan, B. , Jones, R. , Venugopal, B., Mark, P. B. , Lees, J. S. , Petrie, M. C. and Lang, N. N. (2024) Cardiovascular eligibility criteria and adverse event reporting in combined immune checkpoint and VEGF inhibitors trials. JACC: CardioOncology, 6(2), pp. 267-279. (doi: 10.1016/j.jaccao.2023.12.010) (PMID:38774021) (PMCID:PMC11103039)

Chen, D. C. et al. (2024) Cystatin C- and creatinine-based estimated GFR differences: prevalence and predictors in the UK Biobank. Kidney Medicine, 6(4), 100796. (doi: 10.1016/j.xkme.2024.100796) (PMID:8567244) (PMCID:PMC10986041)

Heerspink, H. J.L. et al. (2024) Dapagliflozin and blood pressure in patients with chronic kidney disease and albuminuria. American Heart Journal, 270, pp. 125-135. (doi: 10.1016/j.ahj.2024.02.006) (PMID:38367893)

Shemilt, R. et al. (2024) Sex differences in cancer outcomes across the range of eGFR. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae059) (PMID:38460949) (Early Online Publication)

Adamson, W. E. et al. (2024) Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders. EBioMedicine, 101, 105000. (doi: 10.1016/j.ebiom.2024.105000) (PMID:38360481) (PMCID:PMC10944146)

Balafa, O., Fernandez-Fernandez, B., Ortiz, A., Dounousi, E., Ekart, R., Ferro, C. J., Mark, P. B. , Valdivielso, J. M., Del Vecchio, L. and Mallamaci, F. (2024) Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease. Clinical Kidney Journal, 17(3), sfae044. (doi: 10.1093/ckj/sfae044)

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)

Del Vecchio, L., Balafa, O., Dounousi, E., Ekart, R., Fernandez Fernandez, B., Mark, P. B. , Sarafidis, P., Valdivielso, J. M., Ferro, C. J. and Mallamaci, F. (2024) COVID-19 and cardiovascular disease: Additional risks for patients with chronic kidney disease. Nephrology Dialysis Transplantation, 39(2), pp. 177-189. (doi: 10.1093/ndt/gfad170) (PMID:37771078) (PMCID:PMC10828215)

2023

Mayne, K. J. et al. (2023) Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease. Journal of the American Society of Nephrology, (doi: 10.1681/ASN.0000000000000271) (PMID:38082486) (Early Online Publication)

Andonovic, M., Curle, J., Traynor, J. P., Shaw, M., Sim, M. A.B., Mark, P. B. and Puxty, K. A. (2023) Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors. BJA Open, 8, 100243. (doi: 10.1016/j.bjao.2023.100243) (PMID:38143792) (PMCID:PMC10746363)

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7(4), pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Jani, B. D. , Sullivan, M. K. , Hanlon, P. , Nicholl, B. I. , Lees, J. S. , Brown, L., MacDonald, S. , Mark, P. B. , Mair, F. S. and Sullivan, F. M. (2023) Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role? British Journal of Cancer, (doi: 10.1038/s41416-023-02467-9) (PMID:37880510) (Early Online Publication)

Lees, J. S. and Mark, P. B. (2023) GFR slope as a surrogate marker for future kidney failure. Nature Reviews Nephrology, 19, pp. 625-626. (doi: 10.1038/s41581-023-00748-3) (PMID:37495682)

Lees, J. S. , De La Mata, N. L., Sullivan, M. K. , Wyld, M. L., Rosales, B. M., Cutting, R., Hedley, J. A., Rutherford, E., Mark, P. B. and Webster, A. C. (2023) Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding. European Stroke Journal, 8(3), pp. 756-768. (doi: 10.1177/23969873231173282)

Shemilt, R. et al. (2023) Sex differences in the diagnosis of advanced cancer and subsequent outcome in people with chronic kidney disease: an analysis of a national population cohort. medRxiv, (doi: 10.1101/2023.08.22.23294412)

Hull, K. L. et al. (2023) The NightLife study — the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial. Trials, 24(1), 522. (doi: 10.1186/s13063-023-07565-w) (PMID:37573352) (PMCID:PMC10422763)

Zhou, Z., Parra-Soto, S., Boonpor, J., Petermann-Rocha, F., Welsh, P. , Mark, P. B. , Sattar, N. , Pell, J. P. , Celis-Morales, C. and Ho, F. K. (2023) Exploring the underlying mechanisms linking adiposity and cardiovascular disease: a prospective cohort study of 404,332 UK Biobank participants. Current Problems in Cardiology, 48(8), 101715. (doi: 10.1016/j.cpcardiol.2023.101715) (PMID:37004891)

Elyan, B. M.P. , Rankin, S., Jones, R., Lang, N. N. , Mark, P. B. and Lees, J. S. (2023) Kidney disease patient representation in trials of combination therapy with VEGF-signaling pathway inhibitors and immune checkpoint inhibitors: a systematic review. Kidney Medicine, 5(7), 100672. (doi: 10.1016/j.xkme.2023.100672) (PMID:37492115) (PMCID:PMC10363559)

Lees, J. S. , Dobbin, S. J.H. , Elyan, B. M.P. , Gilmour, D. F., Tomlinson, L. P., Lang, N. N. and Mark, P. B. (2023) A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes. Nephrology Dialysis Transplantation, 38(7), pp. 1666-1681. (doi: 10.1093/ndt/gfac305) (PMID:36318455) (PMCID:PMC10310520)

O’Lone, E. et al. (2023) Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI expert working group. Kidney International, 103(6), pp. 1028-1037. (doi: 10.1016/j.kint.2023.02.033) (PMID:37023851)

Zoccali, C. et al. (2023) Cardiovascular complications in chronic kidney disease - a review from the European Renal and Cardiovascular Medicine Working Group (EURECA-m) of the European Renal Association (ERA). Cardiovascular Research, (doi: 10.1093/cvr/cvad083) (PMID:37249051) (Early Online Publication)

Mark, P. B. et al. (2023) SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease- a comprehensive review by EURECA-m and ERBP working groups of ERA. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfad112) (PMID:37230946) (Early Online Publication)

Lees, J. S. , Elyan, B. M.P., Hermann, S. M., Lang, N. N. , Jones, R. J. and Mark, P. B. (2023) The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrology Dialysis Transplantation, 38(5), pp. 1071-1079. (doi: 10.1093/ndt/gfac011) (PMID:35090037) (PMCID:PMC10157781)

Mark, P. B. et al. (2023) Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study. European Heart Journal, 44(13), pp. 1157-1166. (doi: 10.1093/eurheartj/ehac825) (PMID:36691956)

Mayne, K. J., Lees, J. S. and Mark, P. B. (2023) Cardiovascular complications of chronic kidney disease. Medicine, 51(3), pp. 190-195. (doi: 10.1016/j.mpmed.2022.12.008)

Mayne, K. J., Lees, J. S. , Rutherford, E., Thomson, P. C., Traynor, J. P., Dey, V. , Lang, N. N. and Mark, P. B. (2023) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort. Clinical Kidney Journal, 16(3), pp. 512-520. (doi: 10.1093/ckj/sfac248) (PMID:36865003) (PMCID:PMC9972818)

Kobashigawa, J. A., FellstrÖm, B., Mark, P. B. and Jardine, A. G. (2023) Special patient populations: transplant recipients. In: Ballantyne, C. M. (ed.) Clinical Lipidology: A Companion to Braunwald's Heart Disease [3rd ed.]. Series: Companion to Braunwald's Heart Disease series. Elsevier, 358-366.e2. ISBN 9780323882866 (doi: 10.1016/B978-0-323-88286-6.00037-6)

Mark, P. B. , Jardine, A. G. and Patel, R. K. (2023) Special populations: chronic kidney disease. In: Clinical Lipidology: A Companion to Braunwald's Heart Disease [3rd ed.]. Series: Companion to Braunwald's Heart Disease series. Elsevier, 367-374.e1. ISBN 9780323882866 (doi: 10.1016/B978-0-323-88286-6.00038-8)

Chen, D. C., Lees, J. S. , Lu, K., Scherzer, R., Rutherford, E., Mark, P. B. , Kanaya, A. M., Shlipak, M. G. and Estrella, M. M. (2023) Differential associations of cystatin C versus creatinine‐based kidney function with risks of cardiovascular event and mortality among South Asian individuals in the UK Biobank. Journal of the American Heart Association, 12(3), e027079. (doi: 10.1161/JAHA.122.027079) (PMID:36695320) (PMCID:PMC9973614)

Sullivan, M. K. et al. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73(727), e141-e147. (doi: 10.3399/BJGP.2022.0145) (PMID:36376072) (PMCID:PMC9678375)

Surendrakumar, V. et al. (2023) Cardiorespiratory Optimisation By Arteriovenous fistula Ligation after renal Transplantation (COBALT): study protocol for a multicentre randomised interventional feasibility trial. BMJ Open, 13(2), e067668. (doi: 10.1136/bmjopen-2022-067668) (PMID:36759026) (PMCID:PMC9923321)

Bell, S. et al. (2023) The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland. Clinical Kidney Journal, 16(1), pp. 197-200. (doi: 10.1093/ckj/sfac173) (PMID:36721388) (PMCID:PMC9384465)

Ortiz, A. et al. (2023) Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. Nephrology Dialysis Transplantation, 38(1), pp. 10-25. (doi: 10.1093/ndt/gfab167) (PMID:33944938)

Petrie, M. C. et al. (2023) High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis. Cardiovascular Research, 119(1), pp. 213-220. (doi: 10.1093/cvr/cvab317) (PMID:34875022) (PMCID:PMC10022850)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)

Thöni, S. et al. (2023) International variability of renal and cardiovascular outcomes and mortality in patients with type 2 diabetes mellitus in Europe. Kidney and Blood Pressure Research, 48(1), pp. 165-174. (doi: 10.1159/000528438) (PMID:37015210) (PMCID:PMC10077442)

2022

Lithgow, H. et al. (2022) Protocol for a randomised controlled trial to investigate the effects of vitamin K2 on recovery from muscle-damaging resistance exercise in young and older adults—the TAKEOVER study. Trials, 23, 1026. (doi: 10.1186/s13063-022-06937-y) (PMID:36539791) (PMCID:PMC9764575)

Mark, P. B. , Mangion, K., Rankin, A. J. , Rutherford, E., Lang, N. N. , Petrie, M. C. , Stoumpos, S. and Patel, R. K. (2022) Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients. Clinical Kidney Journal, 15(12), pp. 2186-2199. (doi: 10.1093/ckj/sfac146) (PMID:36381379) (PMCID:PMC9664574)

Mark, P. B. and Sattar, N. (2022) Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease. Lancet, 400(10365), pp. 1745-1747. (doi: 10.1016/S0140-6736(22)02164-X) (PMID:36351457)

Sullivan, M. K. et al. (2022) The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. BMC Medicine, 20, 420. (doi: 10.1186/s12916-022-02628-2) (PMID:36320059) (PMCID:PMC9623942)

Mayne, K. J., Shemilt, R., Keane, D. F., Lees, J. S. , Mark, P. B. and Herrington, W. G. (2022) Bioimpedance indices of fluid overload and cardiorenal outcomes in heart failure and chronic kidney disease: a systematic review. Journal of Cardiac Failure, 28(11), pp. 1628-1641. (doi: 10.1016/j.cardfail.2022.08.005) (PMID:36038013)

Lees, J. S. , Rutherford, E., Stevens, K. I., Chen, D. C., Scherzer, R., Estrella, M. M., Sullivan, M. K. , Ebert, N., Mark, P. B. and Shlipak, M. G. (2022) Assessment of Cystatin C level for risk stratification in adults with chronic kidney disease. JAMA Network Open, 5(10), e2238300. (doi: 10.1001/jamanetworkopen.2022.38300) (PMID:36282503) (PMCID:PMC9597396)

Sundström, J. et al. (2022) Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: the CaReMe CKD study. Lancet Regional Health - Europe, 20, 100438. (doi: 10.1016/j.lanepe.2022.100438) (PMID:36090671) (PMCID:PMC9459126)

Thomson, P. C. et al. (2022) An analysis of vascular access thrombosis events from the Proactive IV Iron Therapy in Hemodialysis Patients (PIVOTAL) trial. Kidney International Reports, 7(8), pp. 1793-1801. (doi: 10.1016/j.ekir.2022.05.008) (PMID:35967105) (PMCID:PMC9366296)

Lee, M. M.Y. et al. (2022) Effect of empagliflozin on kidney biochemical and imaging outcomes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation, 146(4), pp. 364-367. (doi: 10.1161/CIRCULATIONAHA.122.059851) (PMID:35877829)

Mangion, K. et al. (2022) Multi-system investigation of COVID-19 illness. British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, Manchester, UK, 06-08 June 2022. A122.1-A122. (doi: 10.1136/heartjnl-2022-BCS.157)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)

Fard, A., Pearson, R., Lathan, R. , Mark, P. B. and Clancy, M. J. (2022) Perfusate composition and duration of ex-vivo normothermic perfusion in kidney transplantation: a systematic review. Transplant International, 35, 10236. (doi: 10.3389/ti.2022.10236) (PMID:35634582) (PMCID:PMC9130468)

Lees, J. , Rutherford, E., Stevens, K., Chen, D., Scherzer, R., Estrella, M., Sullivan, M. , Ebert, N., Mark, P. and Shlipak, M. (2022) FC077: Cystatin C testing improves risk stratification associated with chronic kidney disease without adopting age-adapted diagnostic thresholds : a UK Biobank Study. Nephrology Dialysis Transplantation, 37(Sup 3), I842-I843. (doi: 10.1093/ndt/gfac114.001)

Stevens, K., Delles, C. , Mark, P. , Thomson, P., Gill, J. , Gray, S. , Ho, F., Rutherford, E. and Lees, J. (2022) MO468: Moving more associates with reduced risk of cardiovascular disease and death across all stages of chronic kidney disease: a UK Biobank study. Nephrology Dialysis Transplantation, 37(Sup 3), i337. (doi: 10.1093/ndt/gfac070.082)

Sullivan, M. , Mark, P. , Mair, F. , Jani, B. , Nitsch, D. and Lees, J. (2022) FC079: The Race-Free EGFR Equation, the kidney failure risk equation and referrals to specialist renal clinics. Nephrology Dialysis Transplantation, 37(Sup 3), i844-i845. (doi: 10.1093/ndt/gfac114.003)

McQuarrie, E. P., Gillis, K. A. and Mark, P. B. (2022) Seven suggestions for successful SGLT2i use in glomerular disease – a standalone CKD therapy? Current Opinion in Nephrology and Hypertension, 31(3), pp. 272-277. (doi: 10.1097/MNH.0000000000000786) (PMID:35220316)

Sullivan, M. K. and Mark, P. B. (2022) Daprodustat in renal anaemia: changing the response to cellular hypoxia, but is it a game changer? Cardiovascular Research, 118(8), e54-e56. (doi: 10.1093/cvr/cvac067) (PMID:35639861)

Banerjee, D. et al. (2022) Management of hypertension in patients with diabetic kidney disease: summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021. Kidney International Reports, 7(4), pp. 681-687. (doi: 10.1016/j.ekir.2022.01.004) (PMID:35497783) (PMCID:PMC9039464)

Bell, S. et al. (2022) The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland. Journal of the American Society of Nephrology, 33(4), pp. 677-686. (doi: 10.1681/ASN.2022010046) (PMID:35110363)

Denicolò, S. et al. (2022) Clonal hematopoiesis of indeterminate potential and diabetic kidney disease: a nested case-control study. Kidney International Reports, 7(4), pp. 876-888. (doi: 10.1016/j.ekir.2022.01.1064) (PMID:35497780) (PMCID:PMC9039487)

Rankin, A. J. , Mayne, K., Allwood-Spiers, S., Hall Barrientos, P., Roditi, G., Gillis, K. A. and Mark, P. B. (2022) Will advances in functional renal magnetic resonance imaging translate to the nephrology clinic? Nephrology, 27(3), pp. 223-230. (doi: 10.1111/nep.13985) (PMID:34724286)

Andonovic, M., Traynor, J. P., Shaw, M., Sim, M. A.B., Mark, P. B. and Puxty, K. A. (2022) Short- and long-term outcomes of intensive care patients with acute kidney disease. EClinicalMedicine, 44, 101291. (doi: 10.1016/j.eclinm.2022.101291) (PMID:35198917) (PMCID:PMC8850318)

Lees, J. S. and Mark, P. B. (2022) Insights into vitamin K metabolism in chronic kidney disease: more complicated than kale deficiency. Kidney International, 101(2), pp. 216-219. (doi: 10.1016/j.kint.2021.11.022) (PMID:35065688)

Sullivan, M. K. et al. (2022) Acute kidney injury in patients hospitalised with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37(2), pp. 271-284. (doi: 10.1093/ndt/gfab303) (PMID:34661677) (PMCID:PMC8788218)

Banerjee, D. et al. (2022) Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021. BMC Nephrology, 23(1), 9. (doi: 10.1186/s12882-021-02587-5) (PMID:34979961) (PMCID:PMC8722287)

Lees, J. S. and Mark, P. B. (2022) Vitamin K supplementation and vascular health after kidney transplantation: authors' response. American Journal of Transplantation, 22(1), pp. 320-321. (doi: 10.1111/ajt.16769) (PMID:34291553)

2021

Ralston, M. R., Stevenson, K. S., Mark, P. B. and Geddes, C. C. (2021) Clinical factors associated with severe hypophosphataemia after kidney transplant. BMC Nephrology, 22, 407. (doi: 10.1186/s12882-021-02624-3)

Crowe, K., Quinn, T. J. , Mark, P. B. and Findlay, M. D. (2021) “Is it removed during dialysis?”—cognitive dysfunction in advanced kidney failure—a review article. Frontiers in Neurology, 12, 787370. (doi: 10.3389/fneur.2021.787370)

Macfarlane, A. J.R. et al. (2021) Anaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) study protocol: a randomised controlled trial comparing primary unassisted patency at 1 year of primary arteriovenous fistulae created under regional compared to local anaesthesia. BMJ Open, 11(12), e052188. (doi: 10.1136/bmjopen-2021-052188) (PMID:34937718) (PMCID:PMC8704953)

Skopalik, S., Hall Barrientos, P., Matthews, J., Radjenovic, A. , Mark, P. , Roditi, G. and Paul, M. C. (2021) Image‐based computational fluid dynamics for estimating pressure drop and fractional flow reserve across iliac artery stenosis: a comparison with in‐vivo measurements. International Journal for Numerical Methods in Biomedical Engineering, 37(12), e3437. (doi: 10.1002/cnm.3437) (PMID:33449429)

Welsh, P. et al. (2021) Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions. European Journal of Preventive Cardiology, 28(18), pp. 1991-2000. (doi: 10.1093/eurjpc/zwaa063) (PMID:33624048)

Mark, P. B. et al. (2021) Stroke in hemodialysis patients randomized to different intravenous iron strategies: a prespecified analysis from the PIVOTAL trial. Kidney360, 2(11), pp. 1761-1769. (doi: 10.34067/KID.0004272021)

Sullivan, M. K. et al. (2021) Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings. BMC Medicine, 19, 278. (doi: 10.1186/s12916-021-02147-6)

Rankin, A. J. et al. (2021) Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal. Journal of Cardiovascular Magnetic Resonance, 23, 125. (doi: 10.1186/s12968-021-00822-4) (PMCID:PMC8580743)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print]. Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Sullivan, M. K. et al. (2021) Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clinical Kidney Journal, 14(11), pp. 2409-2419. (doi: 10.1093/ckj/sfab079) (PMCID:PMC8573008)

Lees, J. S. et al. (2021) The ViKTORIES trial: a randomised, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients. American Journal of Transplantation, 21(10), pp. 3356-3368. (doi: 10.1111/ajt.16566) (PMID:33742520)

Pearson, R., Geddes, C., Mark, P. , Clancy, M. and Asher, J. (2021) Transplantation of kidneys after normothermic perfusion: a single center experience. Clinical Transplantation, 35(10), e14431. (doi: 10.1111/ctr.14431) (PMID:34288129)

Rankin, A. J. et al. (2021) Global longitudinal strain by feature tracking cardiovascular MRI predicts mortality in patients with end stage kidney disease. Clinical Kidney Journal, 14(10), pp. 2187-2196. (doi: 10.1093/ckj/sfab020)

Touyz, R. M. et al. (2021) Cardiovascular and renal risk factors and complications associated with COVID-19. CJC Open, 3(10), pp. 1257-1272. (doi: 10.1016/j.cjco.2021.05.020) (PMID:34151246) (PMCID:PMC8205551)

Singh, S. , Andonovic, M., Traynor, J., Shaw, M., Sim, M., Mark, P. and Puxty, K. (2021) Comparison of De‑novo Acute Kidney Injury in Intensive Care Patients Requiring and not Requiring Renal Replacement Therapy. ESICM LIVES 2021 34th Annual Congress, 3-6 October 2021. (doi: 10.1186/s40635-021-00413-8)

Carr, E. J. et al. (2021) Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet, 398(10305), pp. 1038-1041. (doi: 10.1016/S0140-6736(21)01854-7) (PMID:34391504) (PMCID:PMC8360704)

Stoumpos, S. et al. (2021) Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function. Scientific Reports, 11, 18102. (doi: 10.1038/s41598-021-97625-5) (PMID:34518583) (PMCID:PMC8437985)

Boder, P., Mary, S. , Mark, P. B. , Leiper, J. , Dominiczak, A. F. , Padmanabhan, S. , Rampold, L. and Delles, C. (2021) Mechanistic interactions of uromodulin with the thick ascending limb: perspectives in physiology and hypertension. Journal of Hypertension, 39(8), pp. 1490-1504. (doi: 10.1097/HJH.0000000000002861) (PMID:34187999) (PMCID:PMC7611110)

Collister, D. et al. (2021) Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: a study within a trial. Contemporary Clinical Trials, 107, 106466. (doi: 10.1016/j.cct.2021.106466) (PMID:34098039)

Lees, J. S. et al. (2021) Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine, 38, 101030. (doi: 10.1016/j.eclinm.2021.101030) (PMID:34505030)

Jani, B. D. , Ho, F. K., Lowe, D. J. , Traynor, J. P., MacBride-Stewart, S. P., Mark, P. B. , Mair, F. S. and Pell, J. P. (2021) Comparison of COVID-19 outcomes among shielded and non-shielded populations. Scientific Reports, 11, 15278. (doi: 10.1038/s41598-021-94630-6) (PMID:34315958) (PMCID:PMC8316565)

Valdivielso, J. M., Balafa, O., Ekart, R., Ferro, C. J., Mallamaci, F., Mark, P. B. , Rossignol, P., Sarafidis, P., Del Vecchio, L. and Ortiz, A. (2021) Hyperkalemia in chronic kidney disease in the new era of kidney protection therapies. Drugs, (doi: 10.1007/s40265-021-01555-5) (PMID:34313978)

Jhund, P. S. et al. (2021) Heart failure hospitalization in adults receiving maintenance hemodialysis and effect of intravenous iron therapy: A report from PIVOTAL. JACC: Heart Failure, 9(7), pp. 518-527. (doi: 10.1016/j.jchf.2021.04.005) (PMID:34119470)

Kelly, D. M. et al. (2021) Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference. Stroke, 52(7), e328-e346. (doi: 10.1161/STROKEAHA.120.029680) (PMID:34078109)

Lees, J. S. , Mark, P. B. and Witham, M. D. (2021) Vitamin K and vascular calcification. Current Opinion in Nephrology and Hypertension, 30(4), pp. 430-436. (doi: 10.1097/MNH.0000000000000712) (PMID:33871429)

Li, K. K. et al. (2021) Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. Journal of Infection, 83(1), pp. 96-103. (doi: 10.1016/j.jinf.2021.04.020) (PMID:33895226) (PMCID:PMC8061788)

Edy, E. et al. (2021) Cardiovascular magnetic resonance for the detection of descending thoracic aorta calcification in patients with end-stage renal disease. Journal of Cardiovascular Magnetic Resonance, 23(1), 85. (doi: 10.1186/s12968-021-00769-6) (PMID:34162405) (PMCID:PMC8223384)

Chowdhury, T. A. et al. (2021) Association of british clinical diabetologists and renal association guidelines on the detection and management of diabetes post solid organ transplantation. Diabetic Medicine, 38(6), e14523. (doi: 10.1111/dme.14523) (PMID:33434362)

Lees, J. S. and Mark, P. B. (2021) Fruit for thought: lifestyle interventions to reduce the risk of future chronic kidney disease. Nephrology Dialysis Transplantation, 36(6), pp. 963-965. (doi: 10.1093/ndt/gfaa266) (PMID:33313844)

O’Sullivan, E. D., Lees, J. S. , Howie, K. L., Pugh, D., Gillis, K. A. , Traynor, J. P., Macintyre, I. and Mark, P. B. (2021) Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease. Nephrology, 26(4), pp. 328-332. (doi: 10.1111/nep.13844) (PMID:33368892)

Pearson, R., Asher, J., Jackson, A., Mark, P. B. , Shumeyko, V. and Clancy, M. J. (2021) Viability assessment and utilization of declined donor kidneys with rhabdomyolysis using ex vivo normothermic perfusion without preimplantation biopsy. American Journal of Transplantation, 21(3), pp. 1317-1321. (doi: 10.1111/ajt.16329) (PMID:33021059)

Lee, M. M.Y. et al. (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation, 143(6), pp. 516-525. (doi: 10.1161/CIRCULATIONAHA.120.052186) (PMID:33186500) (PMCID:PMC7864599)

Andonovic, M., Shemilt, R., Sim, M., Traynor, J. P., Shaw, M., Mark, P. B. and Puxty, K. A. (2021) Timing of renal replacement therapy for patients with acute kidney injury: a systematic review and meta-analysis. Journal of the Intensive Care Society, 22(1), pp. 67-77. (doi: 10.1177/1751143720901688) (PMID:33643435) (PMCID:PMC7890756)

Rankin, A. J. and Mark, P. B. (2021) Cardiac screening prior to renal transplantation – good intentions, rather than good evidence, dictate practice. Kidney International, 99(2), pp. 306-308. (doi: 10.1016/j.kint.2020.10.043) (PMID:33509350)

Lees, J. S. and Mark, P. B. (2021) Cystatin C to predict renal disease and cardiovascular risk. Nephrology Dialysis Transplantation, 36(1), pp. 39-41. (doi: 10.1093/ndt/gfaa152) (PMID:32514520)

Mark, P. B. , Del Vecchio, L., Valdivielso, J. M. and Malyszko, J. (2021) Same rhythm, different song - approaches to atrial fibrillation management by cardiologists and nephrologists. Clinical Kidney Journal, 14(1), pp. 9-13. (doi: 10.1093/ckj/sfaa146) (PMID:33564401) (PMCID:PMC7857826)

Rutherford, E. et al. (2021) A randomized, controlled trial of the effect of allopurinol on left ventricular mass index in hemodialysis patients. Kidney International Reports, 6(1), pp. 146-155. (doi: 10.1016/j.ekir.2020.10.025) (PMID:33358501) (PMCID:PMC7590839)

Dounousi, E., Tellis, C., Pavlakou, P., Duni, A., Liakopoulos, V., Mark, P. B. , Papagianni, A. and Tselepis, A. D. (2021) Association between PCSK9 levels and markers of inflammation, oxidative stress, and endothelial dysfunction in a population of nondialysis chronic kidney disease patients. Oxidative Medicine and Cellular Longevity, 2021, 6677012. (doi: 10.1155/2021/6677012) (PMID:34336112) (PMCID:PMC8318757)

Pearson, R., Murray, E. , Thomson, P. C., Mark, P. B. , Clancy, M. J. and Asher, J. (2021) The new UK national kidney allocation scheme with maximized “R4-D4” kidney transplants: better patient-to-graft longevity matching may be at the cost of more resources. Experimental and Clinical Transplantation, 19(11), pp. 1133-1141. (doi: 10.6002/ect.2021.0129) (PMID:34812704)

2020

Kerschbaum, J. et al. (2020) Intra-individual variability of eGFR trajectories in early diabetic kidney disease and lack of performance of prognostic biomarkers. Scientific Reports, 10, 19743. (doi: 10.1038/s41598-020-76773-0) (PMID:33184434) (PMCID:PMC7665005)

Bell, S. et al. (2020) COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry. BMC Nephrology, 21, 419. (doi: 10.1186/s12882-020-02061-8) (PMID:33004002) (PMCID:PMC7528715)

Wheeler, D. C. et al. (2020) The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrology Dialysis Transplantation, 35(10), pp. 1700-1711. (doi: 10.1093/ndt/gfaa234) (PMID:32862232) (PMCID:PMC7538235)

Stoumpos, S., Tan, A., Hall Barrientos, P., Stevenson, K., Thomson, P., Kasthuri, R., Radjenovic, A. , Kingsmore, D., Roditi, G. and Mark, P. (2020) Ferumoxytol MR angiography vs Duplex ultrasound for vascular mapping before arteriovenous fistula surgery for hemodialysis. Radiology, 297(1), pp. 214-222. (doi: 10.1148/radiol.2020200069) (PMID:32692301)

Witham, M. D. et al. (2020) Vitamin K supplementation to improve vascular stiffness in chronic kidney disease: the K4Kidneys randomised controlled trial. Journal of the American Society of Nephrology, 31(10), pp. 2434-2445. (doi: 10.1681/ASN.2020020225) (PMID:32817311)

Cameron, A. C. et al. (2020) Comprehensive characterisation of the vascular effects of cisplatin-based chemotherapy in patients with testicular cancer. JACC: CardioOncology, 2(3), pp. 443-455. (doi: 10.1016/j.jaccao.2020.06.004) (PMID:33043304) (PMCID:PMC7539369)

Price, A. M. et al. (2020) Changes in blood pressure and arterial hemodynamics following living kidney donation. Clinical Journal of the American Society of Nephrology, 15(9), pp. 1330-1339. (doi: 10.2215/CJN.15651219) (PMID:32843374)

McQueenie, R. et al. (2020) Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS ONE, 15(8), e0238091. (doi: 10.1371/journal.pone.0238091) (PMID:32817712) (PMCID:PMC7440632)

Ferguson, A. C. et al. (2020) Alzheimer’s disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769). Journal of Alzheimer's Disease, 76(4), pp. 1541-1551. (doi: 10.3233/JAD-200338) (PMID:32651323)

Christakoudi, S. et al. (2020) Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy. EBioMedicine, 58, 102899. (doi: 10.1016/j.ebiom.2020.102899)

Stoumpos, S. et al. (2020) Ferumoxytol MR angiography: a novel technique for assessing iliac vasculature in potential kidney transplant recipients. JACC: Cardiovascular Imaging, 13(8), pp. 1847-1848. (doi: 10.1016/j.jcmg.2020.02.032) (PMID:32417328)

Lees, J. S. , Mangion, K., Rutherford, E., Witham, M. D., Woodward, R., Roditi, G., Hopkins, T., Brooksbank, K., Jardine, A. and Mark, P. B. (2020) Vitamin K for kidney transplant organ recipients: investigating vEssel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial. Open Heart, 7, e001070. (doi: 10.1136/openhrt-2019-001070) (PMID:32675297) (PMCID:PMC7368482)

Thaventhiran, J. E. D. et al. (2020) Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 583, pp. 90-95. (doi: 10.1038/s41586-020-2265-1) (PMID:32499645)

Sullivan, M. , Rankin, A. , Jani, B. D. , Mair, F. S. and Mark, P. B. (2020) Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. BMJ Open, 10, e038401. (doi: 10.1136/bmjopen-2020-038401) (PMID:32606067) (PMCID:PMC7328898)

Harhay, M. N. and Mark, P. B. (2020) Will universal access to health care mean equitable access to kidney transplantation? Clinical Journal of the American Society of Nephrology, 15(6), pp. 752-754. (doi: 10.2215/CJN.03000320) (PMID:32467308)

Stoumpos, S., Mark, P. , Kingsmore, D., Roditi, G. and Radjenovic, A. (2020) Use of Ferumoxytol enhanced Magnetic Resonance Angiography for cardiovascular assessment in late-stage chronic kidney disease. Documentation. University of Glasgow. (doi: 10.36399/gla.pubs.215112). (Unpublished)

Macdougall, I. C. et al. (2020) Intravenous iron dosing and infection risk in patients on hemodialysis: a prespecified secondary analysis of the PIVOTAL trial. Journal of the American Society of Nephrology, 31(4), 2019090972. (doi: 10.1681/ASN.2019090972) (PMID:32253271)

Rankin, A. J. , Cannon, E., Gillis, K. , Crosby, J., Mark, P. B. , Geddes, C. C., Fox, J. G., Mackinnon, B., McQuarrie, E. and Kipgen, D. (2020) Predicting outcome in acute interstitial nephritis: a case series examining the importance of histological parameters. Histopathology, 76(5), pp. 698-706. (doi: 10.1111/his.14031) (PMID:31691330)

Hockings, P., Laustsen, C., Joles, J., Mark, P. and Sourbron, S. (2020) Special issue on magnetic resonance imaging biomarkers of renal disease. Magnetic Resonance Materials in Physics, Biology and Medicine, 33, pp. 1-2. (doi: 10.1007/s10334-019-00822-7) (PMID:31897904)

Rankin, A. J. et al. (2020) Comparing the interobserver reproducibility of different regions of interest on multi-parametric renal magnetic resonance imaging in healthy volunteers, patients with heart failure and renal transplant recipients. Magnetic Resonance Materials in Physics, Biology and Medicine, 33, pp. 103-112. (doi: 10.1007/s10334-019-00809-4) (PMID:31823275) (PMCID:PMC7021749)

Welsh, C. et al. (2020) Glycated hemoglobin, prediabetes and the links to cardiovascular disease: data from UK Biobank. Diabetes Care, 43(2), pp. 440-445. (doi: 10.2337/dc19-1683) (PMID:31852727)

Mark, P. B. , Papworth, R., Ramparsad, N., Tomlinson, L. A., Sahwney, S., Black, C., McConnachie, A. and McCowan, C. (2020) Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors. British Journal of Clinical Pharmacology, 86(1), pp. 121-131. (doi: 10.1111/bcp.14141) (PMID:31663151)

2019

Mace-Brickman, T., Eddeen, A. B., Carrero, J.-J., Mark, P. B. , Molnar, A. O., Lam, N. N., Zimmerman, D., Harel, Z. and Sood, M. M. (2019) The risk of stroke and stroke type in patients with atrial fibrillation and chronic kidney disease. Canadian Journal of Kidney Health and Disease, 6, pp. 1-9. (doi: 10.1177/2054358119892372)

Kammer, M. et al. (2019) Integrative analysis of prognostic biomarkers derived from multiomics panels for the discrimination of chronic kidney disease trajectories in people with type 2 diabetes. Kidney International, 96(6), pp. 1381-1388. (doi: 10.1016/j.kint.2019.07.025) (PMID:31679767)

Williams, E. H. et al. (2019) Multicentre validation of the CamGFR model for estimated glomerular filtration rate. JNCI Cancer Spectrum, 3(4), pkz068. (doi: 10.1093/jncics/pkz068) (PMID:31750418) (PMCID:PMC6846361)

Grant, C. H. , Gillis, K. A. , Lees, J. S. , Traynor, J. P., Mark, P. B. and Stevens, K. I. (2019) Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis. QJM: An International Journal of Medicine, 112(11), pp. 835-840. (doi: 10.1093/qjmed/hcz166) (PMID:31251364)

Lees, J. S. et al. (2019) Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nature Medicine, 25, pp. 1753-1760. (doi: 10.1038/s41591-019-0627-8) (PMID:31700174) (PMCID:PMC6858876)

Skopalik, S., Hall Barrientos, P., Matthews, J., Radjenovic, A. , Mark, P. , Roditi, G. and Paul, M.C. (2019) FFR and Pressure Drop Assesment across Severe Iliac Artery Stenosis: 4D Fow MRI-based Computational Fluid Dynamics vs. In-vivo Measurements. 31st Society for Magnetic Resonance Angiography Annual Meeting, Nantes, France, 27-30 Aug 2019.

Welsh, C. et al. (2019) Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease: data from UK Biobank. Circulation, 140(7), pp. 542-552. (doi: 10.1161/CIRCULATIONAHA.119.041149) (PMID:31216866) (PMCID:PMC6693929)

Ha, J. T. et al. (2019) Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis. Annals of Internal Medicine, 171(3), pp. 181-189. (doi: 10.7326/M19-0087) (PMID:31307056)

Stapleton, C. P. et al. (2019) The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population. American Journal of Transplantation, 19(8), pp. 2262-2273. (doi: 10.1111/ajt.15326)

Welsh, C. E. , Welsh, P. , Jhund, P. , Sattar, N. and Mark, P. B. (2019) Response by Welsh et al to letter regarding article “Urinary sodium excretion, blood pressure, and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease”. Hypertension, 74, e27-e28. (doi: 10.1161/HYPERTENSIONAHA.119.13349) (PMID:31230548)

Neuberger, J., Armstrong, M. J., Fisher, J., Mark, P. , Schmidtke, K., Sharif, A. and Vlaev, I. (2019) Sport and exercise in improving outcomes after solid organ transplantation: overview from a UK meeting. Transplantation, 103(7S1), S1-S11. (PMID:31259878)

Stoumpos, S., Hennessy, M., Vesey, A. T., Radjenovic, A. , Kasthuri, R., Kingsmore, D. B., Mark, P. B. and Roditi, G. (2019) Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease. European Radiology, 29(7), pp. 3543-3552. (doi: 10.1007/s00330-019-06137-4) (PMID:30919067)

Green, D. et al. (2019) Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study. BMC Nephrology, 20(1), 220. (doi: 10.1186/s12882-019-1406-y) (PMID:31200662)

Clark, A. L., Kalra, P. R., Petrie, M. C. , Mark, P. B. , Tomlinson, L. A. and Tomson, C. R.V. (2019) Change in renal function associated with drug treatment in heart failure: national guidance. Heart, 105(12), pp. 904-910. (doi: 10.1136/heartjnl-2018-314158) (PMID:31118203) (PMCID:PMC6582720)

Lees, J.S. , Chapman, F.A., Witham, M.D., Jardine, A.G. and Mark, P.B. (2019) Vitamin K status, supplementation and vascular disease: a systematic review and meta-analysis. Heart, 105(12), pp. 938-945. (doi: 10.1136/heartjnl-2018-313955) (PMID:30514729)

Stoumpos, S. and Mark, P. B. (2019) Should we ligate arteriovenous fistulas in asymptomatic patients after kidney transplantation? Circulation, 139(25), pp. 2819-2821. (doi: 10.1161/CIRCULATIONAHA.119.040361) (PMID:31206325)

Stoumpos, S., Traynor, J. P., Metcalfe, W., Kasthuri, R., Stevenson, K., Mark, P. B. , Kingsmore, D. B. and Thomson, P. C. (2019) A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population. Journal of Vascular Surgery, 69(6), pp. 1889-1898. (doi: 10.1016/j.jvs.2018.10.063) (PMID:30583903)

Welsh, C. et al. (2019) Urinary sodium excretion, blood pressure and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease. Hypertension, 73, pp. 1202-1209. (doi: 10.1161/HYPERTENSIONAHA.119.12726) (PMID:31067194)

Stapleton, C. P. et al. (2019) Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort. American Journal of Transplantation, 19(3), pp. 801-810. (doi: 10.1111/ajt.15057) (PMID:30085400)

Gillis, K. A. , Lees, J. S. , Ralston, M. R., Glen, J. A., Stevenson, K. S., McManus, S. K., Geddes, C. C., Clancy, M., Traynor, J. P. and Mark, P. B. (2019) Interaction between socioeconomic deprivation and likelihood of pre‐emptive transplantation: influence of competing risks and referral characteristics – a retrospective study. Transplant International, 32(2), pp. 153-162. (doi: 10.1111/tri.13336) (PMID:30152890)

Eder, S. et al. (2019) Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries. Diabetes and Vascular Disease Research, 16(1), pp. 47-56. (doi: 10.1177/1479164118795559) (PMID:30238781)

Findlay, M. D., Dawson, J. , Dickie, D. A. , Forbes, K. P., McGlynn, D., Quinn, T. and Mark, P. B. (2019) Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients. Journal of the American Society of Nephrology, 30(10194), pp. 147-158. (doi: 10.1681/ASN.2018050462) (PMID:30530658) (PMCID:PMC6317612)

Lees, J.S. , Findlay, M.D., Mark, P.B. and Geddes, C.C. (2019) The impact of coronary angiography on renal transplant function. QJM: An International Journal of Medicine, 112(1), pp. 23-27. (doi: 10.1093/qjmed/hcy216) (PMID:30295913)

Findlay, M., Macisaac, R., MacLeod, M. J., Metcalfe, W., Sood, M. M., Traynor, J. P., Dawson, J. and Mark, P. B. (2019) The association of atrial fibrillation and ischaemic stroke in patients on haemodialysis: a competing risk analysis. Canadian Journal of Kidney Health and Disease, 6, pp. 1-13. (doi: 10.1177/2054358119878719) (PMID:31632680) (PMCID:PMC6767723)

Mark, P. B. and Denby, L. (2019) Renal disease. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 409-417. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_38)

Skopalik, S., Hall Barrientos, P., Matthews, J., Radjenovic, A. , Mark, P. , Roditi, G. and Paul, M.C. (2019) Image-based Computational Fluid Dynamics for Estimating Pressure Drop and FFR Across Iliac Artery Stenosis: a Comprison with In-vivo Measurements. In: 6th International Conference on Computational and Mathematical Biomedical Engineering (CMBE 2019), Sendai City, Japan, 10-12 Jun 2019, pp. 809-812. ISBN 9780956291455

2018

Ferro, C. J. et al. (2018) Lipid management in patients with chronic kidney disease. Nature Reviews Nephrology, 14(12), pp. 727-749. (doi: 10.1038/s41581-018-0072-9) (PMID:30361677)

Christakoudi, S. et al. (2018) Steroid regulation: an overlooked aspect of tolerance and chronic rejection in kidney transplantation. Molecular and Cellular Endocrinology, 473, pp. 205-216. (doi: 10.1016/j.mce.2018.01.021) (PMID:29427591)

Findlay, M., MacIsaac, R., MacLeod, M. J., Metcalfe, W., Traynor, J. P., Dawson, J. and Mark, P. B. (2018) Renal replacement modality and stroke risk in end-stage renal disease—a national registry study. Nephrology Dialysis Transplantation, 33(9), pp. 1564-1571. (doi: 10.1093/ndt/gfx291) (PMID:29069522)

Findlay, M. D., Dawson, J. , MacIsaac, R., Jardine, A. G. , MacLeod, M. J., Metcalfe, W., Traynor, J. P. and Mark, P. B. (2018) Inequality in care and differences in outcome following stroke in people with end stage renal disease: results from a national registry linkage analysis. Kidney International Reports, 3(5), pp. 1064-1076. (doi: 10.1016/j.ekir.2018.04.011) (PMID:30197973) (PMCID:PMC6127409)

Kammer, M. et al. (2018) Validation of plasma biomarker candidates for the prediction of eGFR decline in patients with type 2 diabetes. Diabetes Care, 41(9), pp. 1947-1954. (doi: 10.2337/dc18-0532) (PMID:29980527) (PMCID:PMC6105325)

Selby, N. M. et al. (2018) Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA. Nephrology Dialysis Transplantation, 33(suppl2), ii4-ii14. (doi: 10.1093/ndt/gfy152) (PMID:30137584)

Gillis, K. , Stevens, K. K., Bell, E., Patel, R. K., Jardine, A. G. , Morris, S. T.W., Schneider, M. P., Delles, C. and Mark, P. B. (2018) Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease. Clinical Kidney Journal, 11(4), pp. 532-539. (doi: 10.1093/ckj/sfx158) (PMID:30094018) (PMCID:PMC6070083)

Welsh, P. et al. (2018) Circulating amino acids and the risk of macrovascular, microvascular, and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial. Diabetologia, 61(7), pp. 1581-1591. (doi: 10.1007/s00125-018-4619-x) (PMID:29728717) (PMCID:PMC6445481)

Hernandez-Fuentes, M. P. et al. (2018) Long‐ and short‐term outcomes in renal allografts with deceased donors: a large recipient and donor genome‐wide association study. American Journal of Transplantation, 18(6), pp. 1370-1379. (doi: 10.1111/ajt.14594) (PMID:29392897)

Welsh, C. et al. (2018) Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(6), pp. 1415-1423. (doi: 10.1161/ATVBAHA.118.310945) (PMID:29699973)

Evans, M. et al. (2018) Risk factors for prognosis in patients with severely decreased GFR. Kidney International Reports, 3(3), pp. 625-637. (doi: 10.1016/j.ekir.2018.01.002) (PMID:29854970) (PMCID:PMC5976849)

Mark, P. , Dekkers, I., Blankestijn, P., Leiner, T. and Roditi, G. (2018) Letter on 'European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis'. Journal of the European Academy of Dermatology and Venereology, 32(2), e84-e85. (doi: 10.1111/jdv.14774) (PMID:29283443)

Persu, A. et al. (2018) Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis. Journal of Hypertension, 36(2), pp. 221-229. (doi: 10.1097/HJH.0000000000001582) (PMID:29045339)

Stoumpos, S., Lees, J. , Welsh, P. , Hund, M., Geddes, C. C., Nelson, S. M. and Mark, P. B. (2018) The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation. Reproductive BioMedicine Online, 36(2), pp. 219-226. (doi: 10.1016/j.rbmo.2017.11.003) (PMID:29233504)

Taylor, A. H.M., Rankin, A. J. , McQuarrie, E. P., Freel, M., Homer, N. Z.M., Andrew, R., Jardine, A. G. and Mark, P. B. (2018) Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease. Clinical Science, 132(2), pp. 285-294. (doi: 10.1042/CS20171603) (PMID:29321218)

Mark, P. B. (2018) Strategies to manage cardiovascular risk in chronic kidney disease. Nephrology Dialysis Transplantation, 33(1), pp. 23-25. (doi: 10.1093/ndt/gfx329) (PMID:29237023)

Solbu, M. D., Mjøen, G., Mark, P. B. , Holdaas, H., Fellström, B., Schmieder, R. E., Zannad, F., Herrington, W. G. and Jardine, A. G. (2018) Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA Study. Nephrology Dialysis Transplantation, 33(1), pp. 102-112. (doi: 10.1093/ndt/gfw360) (PMID:27798199)

Mangion, K., McDowell, K., Mark, P. B. and Rutherford, E. (2018) Characterizing cardiac involvement in chronic kidney disease using CMR—a systematic review. Current Cardiovascular Imaging Reports, 11, 2. (doi: 10.1007/s12410-018-9441-9) (PMID:29497467) (PMCID:PMC5818546)

Stoumpos, S., Hennessy, M., Vesey, A. T., Radjenovic, A. , Kasthuri, R., Kingsmore, D. B., Mark, P. B. and Roditi, G. (2018) Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients. European Radiology, 28(1), pp. 115-123. (doi: 10.1007/s00330-017-4934-5) (PMID:28677065) (PMCID:PMC5717122)

Eder, S. et al. (2018) A prospective cohort study in patients with type 2 diabetes mellitus for validation of biomarkers (PROVALID) –study design and baseline characteristics. Kidney and Blood Pressure Research, 43(1), pp. 181-190. (doi: 10.1159/000487500)

2017

Rutherford, E., Stewart, G., Houston, J. G., Jardine, A. G. , Mark, P. B. and Struthers, A. D. (2017) An open-label dose-finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients. Journal of Clinical Pharmacology, 57(11), pp. 1409-1414. (doi: 10.1002/jcph.939) (PMID:28597919)

Rutherford, E. et al. (2017) Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study. Scientific Reports, 7, 13976. (doi: 10.1038/s41598-017-14481-y) (PMID:29070834) (PMCID:PMC5656609)

Stevens, K., Denby, L., Patel, R. K., Mark, P. B. , Kettlewell, S., Smith, G. L. , Clancy, M. J., Delles, C. and Jardine, A. G. (2017) Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway. Nephrology Dialysis Transplantation, 32(10), pp. 1617-1627. (doi: 10.1093/ndt/gfw252) (PMID:27448672) (PMCID:PMC5837731)

Sanders, M. F. et al. (2017) Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography. European Radiology, 27(9), pp. 3934-3941. (doi: 10.1007/s00330-017-4770-7) (PMID:28271154)

Janowitz, T. et al. (2017) New model for estimating glomerular filtration rate in patients with cancer. Journal of Clinical Oncology, (doi: 10.1200/JCO.2017.72.7578) (PMID:28686534)

Findlay, M. D. and Mark, P. B. (2017) Reduced and declining physical function in prevalent dialysis patients – identifying the vulnerable. Age and Ageing, 46(4), pp. 541-543. (doi: 10.1093/ageing/afx049) (PMID:28407065)

Baker, R. J., Mark, P. B. , Patel, R. K., Stevens, K. K. and Palmer, N. (2017) Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrology, 18, 174. (doi: 10.1186/s12882-017-0553-2) (PMID:28571571) (PMCID:PMC5455080)

Ritchie, J. et al. (2017) Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation, 32(6), pp. 1006-1013. (doi: 10.1093/ndt/gfw107) (PMID:27257278)

Ptinopoulou, A. G., Pikilidou, M. I., Tziolas, I. M., Haidich, A.-B., Mark, P. B. , Zebekakis, P. E. and Lasaridis, A. N. (2017) Changes in kidney function in a population with essential hypertension in real life settings. Iranian Journal of Kidney Disease, 11(3), pp. 192-200. (PMID:28575879)

Sarafidis, P. A. et al. (2017) Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Journal of Hypertension, 35(4), pp. 657-676. (doi: 10.1097/HJH.0000000000001283) (PMID:28157814)

Sarafidis, P. A. et al. (2017) Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrology Dialysis Transplantation, 32(4), pp. 620-640. (doi: 10.1093/ndt/gfw433) (PMID:28340239)

Dawson, J. and Mark, P. B. (2017) Uric acid and decline in renal function-partners in crime. American Journal of Nephrology, 45(4), pp. 327-329. (doi: 10.1159/000464261) (PMID:28285315)

Rutherford, E. and Mark, P.B. (2017) What happens to the heart in chronic kidney disease? Journal of the Royal College of Physicians of Edinburgh, 47(1), pp. 76-82. (doi: 10.4997/JRCPe.2017.117) (PMID:28569289)

Graham-Brown, M. P.M. et al. (2017) Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients. Journal of Cardiovascular Magnetic Resonance, 19, 21. (doi: 10.1186/s12968-017-0337-7) (PMID:28238284) (PMCID:PMC5327541)

Rutherford, E., Weir-McCall, J. R., Patel, R. K., Houston, J. G., Roditi, G., Struthers, A. D., Jardine, A. G. and Mark, P. B. (2017) Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings. European Radiology, 27(1), pp. 315-324. (doi: 10.1007/s00330-016-4288-4) (PMID:27053260)

Stoumpos, S., Mark, P. B. , McQuarrie, E. P., Traynor, J. P. and Geddes, C. C. (2017) Continued monitoring of acute kidney injury survivors might not be necessary in those regaining an estimated glomerular filtration rate > 60 mL/min at 1 year. Nephrology Dialysis Transplantation, 32(1), pp. 81-88. (doi: 10.1093/ndt/gfw413)

2016

Rebollo-Mesa, I. et al. (2016) Biomarkers of tolerance in kidney transplantation - are we predicting tolerance or response to immunosuppressive treatment? American Journal of Transplantation, 16(12), pp. 3443-3457. (doi: 10.1111/ajt.13932) (PMID:27328267) (PMCID:PMC5132071)

Herrington, W. G. et al. (2016) Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes and Endocrinology, 4(10), pp. 829-839. (doi: 10.1016/S2213-8587(16)30156-5) (PMID:27477773)

Rutherford, E. et al. (2016) Definition of myocardial tissue abnormalities in end stage renal failure with cardiac magnetic resonance imaging using T1 mapping. Kidney International, 90(4), pp. 845-852. (doi: 10.1016/j.kint.2016.06.014)

Currie, G. et al. (2016) Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology, 17, 127. (doi: 10.1186/s12882-016-0337-0) (PMID:27609359) (PMCID:PMC5015203)

Findlay, M. D. et al. (2016) Risk factors and outcome of stroke in renal transplant recipients. Clinical Transplantation, 30(8), pp. 918-924. (doi: 10.1111/ctr.12765) (PMID:27218240)

Sharp, A. S. P. et al. (2016) Renal artery sympathetic denervation: observations from the UK experience. Clinical Research in Cardiology, 105(6), pp. 544-552. (doi: 10.1007/s00392-015-0959-4) (PMID:26802018)

Gillis, K. A. , Mccomb, C., Patel, R. K., Stevens, K. K., Schneider, M. P., Radjenovic, A. , Morris, S. T.W., Roditi, G. H., Delles, C. and Mark, P. B. (2016) Non-contrast renal magnetic resonance imaging to assess perfusion and corticomedullary differentiation in health and chronic kidney disease. Nephron, 133(3), pp. 183-192. (doi: 10.1159/000447601) (PMID:27362585)

Rutherford, E. and Mark, P. (2016) What does STOP-IgAN tell us about how to treat IgA nephropathy? Journal of the Royal College of Physicians of Edinburgh, 46(1), pp. 23-25. (doi: 10.4997/JRCPE.2016.107)

Stoumpos, S., McNeill, S. H., Gorrie, M., Mark, P. B. , Brennand, J. E., Geddes, C. C. and Deighan, C. J. (2016) Obstetric and long-term kidney outcomes in renal transplant recipients: a 40 year single-centre study. Clinical Transplantation, 30(6), pp. 673-681. (doi: 10.1111/ctr.12732) (PMID:26992458)

2015

Solbu, M. D., Thomson, P. C., Macpherson, S., Findlay, M. D., Stevens, K. K., Patel, R. K., Padmanabhan, S. , Jardine, A. G. and Mark, P. B. (2015) Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease. BMC Nephrology, 16, 194. (doi: 10.1186/s12882-015-0187-1) (PMID:26627078) (PMCID:PMC4666082)

Patel, R., Jeemon, P., Stevens, K., Mccallum, L., Hastie, C. , Schneider, A., Jardine, A. , Mark, P. and Padmanabhan, S. (2015) Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults. Journal of Hypertension, 33(10), pp. 2046-2053. (doi: 10.1097/hjh.0000000000000659) (PMID:26431193)

Findlay, M. D., Thomson, P. C., Fulton, R. L., Solbu, M. D., Jardine, A. G. , Patel, R. K., Stevens, K. K., Geddes, C. C., Dawson, J. and Mark, P. B. (2015) Risk factors of ischemic stroke and subsequent outcome in hemodialysis patients. Stroke, 46(9), pp. 2477-2481. (doi: 10.1161/STROKEAHA.115.009095) (PMID:26230856)

Lees, J. S. , Mark, P. B. and Jardine, A. G. (2015) Cardiovascular complications of chronic kidney disease. Medicine, 43(8), pp. 469-473. (doi: 10.1016/j.mpmed.2015.05.009)

Mann, J. F.E., Rossing, P., Wiȩcek, A., Rosivall, L., Mark, P. and Mayer, G. (2015) Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs? Nephrology Dialysis Transplantation, 30(Sup 4), iv1-iv5. (doi: 10.1093/ndt/gfv120) (PMID:26209731)

Rutherford, M.A., Rankin, A.J. , Yates, T.M., Mark, P.B. , Perry, C.G., Reed, N.S. and Freel, E.M. (2015) Management of metastatic phaeochromocytoma and paraganglioma: use of Iodine-131-meta-iodobenzylguanidine (131I-MIBG) therapy in a tertiary referral centre. QJM: An International Journal of Medicine, 108(5), pp. 361-368. (doi: 10.1093/qjmed/hcu208) (PMID:25267727)

Stoumpos, S., Jardine, A. G. and Mark, P. B. (2015) Cardiovascular morbidity and mortality after kidney transplantation. Transplant International, 28(1), pp. 10-21. (doi: 10.1111/tri.12413) (PMID:25081992)

2014

Mark, P. B., Schiffrin, E. L., Jennings, G. L., Dominiczak, A. F. , Wang, J.-G., De Buyzere, M. and Staessen, J. A. (2014) Renovascular hypertension: to stent or not to stent? Hypertension, 64(6), pp. 1165-1168. (doi: 10.1161/HYPERTENSIONAHA.114.04497)

Persu, A. et al. (2014) Hyperresponders vs. nonresponder patients after renal denervation: do they differ? Journal of Hypertension, 32(12), pp. 2422-2427. (doi: 10.1097/HJH.0000000000000347)

Mark, P. B. , Taylor, A. H. M., McQuarrie, E. P. and Jardine, A. G. (2014) How is the heart best protected in chronic dialysis patients? Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patients. Seminars in Dialysis, 27(4), pp. 328-332. (doi: 10.1111/sdi.12178)

McQuarrie, E. P., Traynor, J. P., Taylor, A. H., Freel, E. M., Fox, J. G., Jardine, A. G. and Mark, P. (2014) Association between urinary sodium, creatinine, albumin, and long term survival in chronic kidney disease. Hypertension, 64(1), pp. 111-117. (doi: 10.1161/HYPERTENSIONAHA.113.03093)

Persu, A. et al. (2014) Eligibility for renal denervation: experience at 11 European expert centers. Hypertension, 63(6), pp. 1319-25. (doi: 10.1161/HYPERTENSIONAHA.114.03194) (PMID:24664290)

Shepherd, S. T.C., Gillen, G., Morrison, P., Forte, C., MacPherson, I. R. , White, J. D. and Mark, P. B. (2014) Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma. European Journal of Cancer, 50(5), pp. 944-952. (doi: 10.1016/j.ejca.2013.12.021)

Persu, A. et al. (2014) Blood pressure changes after renal denervation at 10 European expert centers. Journal of Human Hypertension, 28(3), pp. 150-156. (doi: 10.1038/jhh.2013.88)

Mark, P.B. , Boyle, S., Zimmerli, L.U., McQuarrie, E.P., Delles, C. and Freel, E.M. (2014) Alterations in vascular function in primary aldosteronism - a cardiovascular magnetic resonance imaging study. Journal of Human Hypertension, 28(2), pp. 92-97. (doi: 10.1038/jhh.2013.70)

Moody, W.E., Tomlinson, L.A., Ferro, C.J., Steeds, R.P., Mark, P.B. , Zehnder, D., Tomson, C.R., Cockcroft, J.R., Wilkinson, I.B. and Townend, J.N. (2014) Effect of a reduction in glomerular filtration rate after nephrectomy on arterial stiffness and central hemodynamics: rationale and design of the EARNEST study. American Heart Journal, 167(2), 141-149.e2. (doi: 10.1016/j.ahj.2013.10.024)

Gillis, K.A. et al. (2014) Inter-study reproducibility of arterial spin labelling magnetic resonance imaging for measurement of renal perfusion in healthy volunteers at 3 Tesla. BMC Nephrology, 15(23), (doi: 10.1186/1471-2369-15-23)

Patel, R.K., Geddes, C.C. and Mark, P.B. (2014) Intrarenal resistive index after renal transplantation. New England Journal of Medicine, 370(7), pp. 676-678. (doi: 10.1056/NEJMc1315502)

Patel, R. K., Pennington, C., Stevens, K. K., Taylor, A., Gillis, K. , Rutherford, E., Johnston, N., Jardine, A. G. and Mark, P. B. (2014) Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome—a single-center study. Transplantation Research, 3(20), (doi: 10.1186/s13737-014-0020-6)

Shepherd, S. T.C., Macpherson, I. R., White, J. D. and Mark, P. B. (2014) Response to: ‘Letter to the editor, European Journal of Cancer’, commenting on ‘Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma’. European Journal of Cancer, 25(7), pp. 1497-1503. (doi: 10.1016/j.ejca.2014.04.027)

2013

McQuarrie, E.P., Freel, E.M., Mark, P.B. , Fraser, R., Connell, J.M.C. and Jardine, A.G. (2013) Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease. Nephrology Dialysis Transplantation, 28(6), pp. 1526-1532. (doi: 10.1093/ndt/gft007)

Mark, P. , Stevens, K. and Jardine, A. (2013) Electrolytes: acid–base balance. In: Caballero, B., Allen, L. and Prentice, A. (eds.) Encyclopedia of Human Nutrition. Academic Press: Waltham, MA, pp. 139-145. ISBN 9780123750839

2012

Freel, E. M., Mark, P. B. , Weir, R. A.P., McQuarrie, E. P., Allan, K., Dargie, H. J., McClure, J. D. , Jardine, A. G. , Davies, E. and Connell, J. M.C. (2012) Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study. Circulation: Cardiovascular Imaging, 5(6), pp. 740-747. (doi: 10.1161/CIRCIMAGING.112.974576)

McQuarrie, E. P., Freel, E. M., Mark, P. B. , Fraser, R., Patel, R. K., Dargie, H. G., Connell, J. M. C. and Jardine, A. G. (2012) Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease. Clinical Science, 123(5), pp. 285-294. (doi: 10.1042/CS20120015)

Mark, P. and Jardine, A. (2012) Assessment of the potential renal transplant recipient. In: MacPhee, I. A. M. and Froněck, J. (eds.) Handbook of Renal and Pancreatic Transplantation. Wiley-Blackwell: Oxford, pp. 8-31. ISBN 9780470654910

Patel, R.K., Mark, P.B. , Macnaught, G., Stevens, K.K., McQuarrie, E.P., Steedman, T., Gillis, K. , Dargie, H.J. and Jardine, A.G. (2012) Altered relative concentrations of high-energy phosphates in patients with uraemic cardiomyopathy measured by magnetic resonance spectroscopy. Nephrology Dialysis Transplantation, 27(6), pp. 2446-2451. (doi: 10.1093/ndt/gfr688)

2011

McQuarrie, E.P., Patel, R.K., Mark, P.B. , Delles, C. , Connell, J., Dargie, H.J., Steedman, T. and Jardine, A.G. (2011) Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease. Nephrology Dialysis Transplantation, 26(3), pp. 933-938. (doi: 10.1093/ndt/gfq418)

Patel, R.K., Mark, P.B. , Halliday, C., Steedman, T., Dargie, H. J., Cobbe, S.M. and Jardine, A.G. (2011) Microvolt T-Wave Alternans in End-Stage Renal Disease Patients--Associations with Uremic Cardiomyopathy. Clinical Journal of the American Society of Nephrology, 6(3), pp. 519-527. (doi: 10.2215/CJN.06370710)

Stevens, K.K., Morgan, I.R., Patel, R.K., Geddes, C.C., Mark, P.B. , Jardine, A.G. and Delles, C. (2011) Serum phosphate and outcome at one year after deceased donor renal transplantation. Clinical Transplantation, 25(2), E199-E204. (doi: 10.1111/j.1399-0012.2011.01400.x)

Stevens, K.K., McQuarrie, E.P., Sands, W., Hillyard, D.Z., Patel, R.K., Mark, P.B. and Jardine, A.G. (2011) Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formation. International Journal of Nephrology, 2011(297070), pp. 1-6. (doi: 10.4061/2011/297070)

2010

Collidge, T., Thomson, P., Mark, P. , Willinek, W. and Roditi, G. (2010) Is this really a true case of NSF following Gadovist exposure alone? Nephrology Dialysis Transplantation, 25(4), pp. 1352-1353. (doi: 10.1093/ndt/gfq014)

Mark, P. B. , Patel, R. K. and Jardine, A. G. (2010) Screening for Coronary Artery Disease Before Renal Transplantation-Rational or Rationing? Transplantation, 89(7), pp. 807-808. (doi: 10.1097/TP.0b013e3181cca6b6)

Patel, R.K., Jardine, A.G.M. , Mark, P.B. , Cunningham, A.F., Steedman, T., Powell, J.R., McQuarrie, E.P., Stevenson, K.K., Dargie, H.J. and Jardine, A.G. (2010) Association of left atrial volume with mortality among esrd patients with left ventricular hypertrophy referred for kidney transplant. American Journal of Kidney Diseases, 55(6), pp. 1088-1096. (doi: 10.1053/j.ajkd.2009.12.033)

Thomson, P. C., Collidge, T. A., Mark, P.B. , Traynor, J.P., Jardine, A.G. , Morris, S. T. W., Simpson, K. and Roditi, G. H. (2010) Correction to the Relative Risk Calculation for Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis Response. Radiology, 255(1), p. 308.

2009

Mark, P., Mccrea, I.V., Baxter, G.M. and McMillan, M. (2009) Hydronephrosis in a pregnant renal transplant patient. Transplantation Proceedings, 41(9), pp. 3962-3963. (doi: 10.1016/j.transproceed.2009.05.031)

Patel, R., Oliver, S., Mark, P., Powell, J., McQuarrie, E., Traynor, J., Dargie, H. and Jardine, A. (2009) Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging. Clinical Journal of the American Society of Nephrology, 4(9), pp. 1477-1483. (doi: 10.2215/CJN.03350509)

Mark, P. B. , Jardine, A. G. , Roditi, G. H. and Brady, A. J. (2009) Renal artery stenosis. In: Donnelly, R. and London, N. J. (eds.) ABC of Arterial and Venous Disease. Series: BMJ Books. Wiley-Blackwell: Oxford, pp. 37-43. ISBN 9781405178891

Jardine, A. G. , Mark, P. B. , Holdaas, H. and Fellstrøm, B. (2009) Special patient populations: chronic renal disease. In: Ballantyne, C. M. (ed.) Lipidology: A Companion To Braunwald's Heart Disease. Elsevier: Oxford, pp. 500-508. ISBN 9781416054696

Weir, R. A.P., Chong, K. S., Dalzell, J. R., Petrie, C. J., Murphy, C. A., Steedman, T., Mark, P.B. , McDonagh, T. A., Dargie, H. J. and McMurray, J. J.V. (2009) Plasma apelin concentration is depressed following acute myocardial infarction in man. European Journal of Heart Failure, 11(6), pp. 551-558. (doi: 10.1093/eurjhf/hfp043)

Weir, R.A.P., Mark, P.B. , Petrie, C.J., Clements, S., Steedman, T., Ford, I. , Ng, L.L., Squire, I.B., Wagner, G.S. and McMurray, J.J.V. (2009) Left ventricular remodeling after acute myocardial infarction: Does eplerenone have an effect? American Heart Journal, 157(6), pp. 1088-1096. (doi: 10.1016/j.ahj.2009.04.001)

2008

Patel, R., Mark, P., Johnston, N., McGeoch, R., Lindsay, M., Dargie, H. and Jardine, A. (2008) Cardiovascular screening of potential renal transplant recipients provides no survival benefit. American Journal of Transplantation, 8(s2), pp. 597-598. (doi: 10.1111/j.1600-6143.2008.02255.x)

Weir, R. A.P., Mark, P. B. , Petrie, C. J., Murphy, A., Clements, S., Steedman, T. and Dargie, H. J. (2008) Late-developing massive left ventricular thrombus following myocardial infarction. Clinical Cardiology, 31(5), pp. 233-234. (doi: 10.1002/clc.20013)

Edward, M., Quinn, J.A., Mukherjee, S., Jensen, M.B., Jardine, A.G., Mark, P. and Burden, A. (2008) Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. Journal of Pathology, 214(5), pp. 584-593. (doi: 10.1002/path.2311)

Doyle, A., Mark, P.B. , Johnston, N., Foster, J., Connell, J., Dargie, H., Jardine, A. and Padmanabhan, N. (2008) Aortic stiffness and diastolic flow abnormalities in end-stage renal disease assessed by magnetic resonance imaging. Nephron Clinical Practice, 109(1), C1-C8. (doi: 10.1159/000130170)

Mark, P., Doyle, A., Blyth, K., Patel, R., Weir, R., Steedman, T., Foster, J., Dargie, H. and Jardine, A. (2008) Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease. Journal of Cardiovascular Magnetic Resonance, 10(39), (doi: 10.1186/1532-429X-10-39)

Patel, R.K., Mark, P.B. , Johnston, N., McGeoch, R., Lindsay, M., Kingsmore, D.B., Dargie, H.J. and Jardine, A.G. (2008) Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. American Journal of Transplantation, 8(8), pp. 1673-1683. (doi: 10.1111/j.1600-6143.2008.02281.x)

Patel, R., Mark, P., Johnston, N., McGregor, E., Dargie, H. and Jardine, A. (2008) Renal Transplantation Is Not Associated with Regression of Left Ventricular Hypertrophy: A Magnetic Resonance Study. Clinical Journal of the American Society of Nephrology, 3(6), pp. 1807-1811. (doi: 10.2215/CJN.01400308)

Petrie, C., Mark, P. and Weir, R. (2008) Broken pump or leaky filter? Renal dysfunction in heart failure a contemporary review. International Journal of Cardiology, 128(2), pp. 154-165.

2007

Mark, P. B. , Petrie, C. J. and Jardine, A. G. (2007) Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure. Seminars in Dialysis, 20, pp. 40-49. (doi: 10.1111/j.1525-139X.2007.00240.x)

Blyth, K., Dargie, H., Foster, J., Groenning, B., Mark, P., Martin, T., Morton, J., Peacock, A. and Steedman, T. (2007) NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. European Respiratory Journal, 29, pp. 737-744. (doi: 10.1183/09031936.00095606)

Collidge, T., Jardine, A., Mark, P., Morris, S., Roditi, G., Simpson, K., Thomson, P. and Traynor, J. (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort. Radiology, 245(1), pp. 168-175.

Collidge, T., Mark, P., Thomson, P. and Traynor, J. (2007) Imaging peripheral disease - Ga dolinium contrast may be risky in kidney disease. British Medical Journal, 334(7608), pp. 1335-1336.

Hillyard, D., Nutt, C., Thomson, J., McDonald, K., Wan, R., Cameron, A., Mark, P. and Jardine, A. (2007) Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis, 191, pp. 319-325. (doi: 10.1016/j.atherosclerosis.2006.05.037)

Mark, P. B. , Patel, R. K. and Jardine, A. G. (2007) Are we overestimating left ventricular abnormalities in end-stage renal disease? Nephrology Dialysis Transplantation, 22(7), pp. 1815-1819. (doi: 10.1093/ndt/gfm224)

Wan, R., Mark, P. and Jardine, A. (2007) The cholesterol paradox is flawed; Cholesterol must be lowered in dialysis patients. Seminars in Dialysis, 20, pp. 504-509. (doi: 10.1111/j.1525-139X.2007.00359.x)

Zimmerli, L., Mark, P., Steedman, T., Foster, J., Berg, G., Dargie, H., Jardine, A., Delles, C. and Dominiczak, A. (2007) Vascular function in patients with end-stage renal disease and/or coronary artery disease: A cardiac magnetic resonance imaging study. Kidney International, 71(1), pp. 68-73. (doi: 10.1038/sj.ki.5002024)

2006

Wan, R. K., Mark, P. B. and Jardine, A. G. (2006) Cardiovascular disease management in renal transplant recipients: more or less treatment? Transplantation, 82(6), pp. 737-738. (doi: 10.1097/01.tp.0000235431.71677.e3)

Mark, P.B. and Jardine, A.G. (2006) Cardiovascular magnetic resonance imaging has much to offer in the assessment of renal transplant recipients. American Journal of Transplantation, 6(8), pp. 1975-1976. (doi: 10.1111/j.1600-6143.2006.01376.x)

Mark, P. and Wan, R. (2006) Infected right atrial thrombus associated with a tunneled hemodialysis catheter. Kidney International, 69(9), p. 1489.

Mark, P.B. , Johnston, N., Groenning, B.A., Foster, J.E., Blyth, K.G., Martin, T.N., Steedman, T., Dargie, H.J. and Jardine, A.G. (2006) Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney International, 69(10), pp. 1839-1845. (doi: 10.1038/sj.ki.5000249)

Mark, P., Stewart, G., Gansevoort, R., Petrie, C., McDonagh, T., Dargie, H., Rodger, R. and Jardine, A. (2006) Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrology Dialysis Transplantation, 21, pp. 402-410. (doi: 10.1093/ndt/gfi187)

2005

Mark, P.B. , Murphy, K., Mohammed, A.S., Morris, S.T.W. and Jardine, A.G. (2005) Endothelial dysfunction in renal transplant recipients. Transplantation Proceedings, 37(9), pp. 3805-3807. (doi: 10.1016/j.transproceed.2005.09.116)

Tutone, V.K., Mark, P.B. , Stewart, G.A., Tan, C.C., Rodger, R.S.C., Geddes, C.C. and Jardine, A.G. (2005) Hypertension, antihypertensive agents and outcomes following renal transplantation. Clinical Transplantation, 19(2), pp. 181-192. (doi: 10.1111/j.1399-0012.2004.00315.x)

Stewart, G., Gansevoort, R., Mark, P., Rooney, E., McDonagh, T., Dargie, H., Stuart, R., Rodger, C. and Jardine, A. (2005) Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney International, 67(1), pp. 217-226. (doi: 10.1111/j.1523-1755.2005.00072.x)

Blyth, K., Dargie, H., Foster, J., Groenning, B., Mark, P., Martin, T. and Peacock, A. (2005) Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. European Heart Journal, 26, pp. 1993-1999. (doi: 10.1093/eurheartj/ehi328)

Dargie, H., Mark, P. and Petrie, C. (2005) Cardiomyopathy in Becker muscular dystrophy - does regional fibrosis mimic infarction? Journal of Cardiovascular Magnetic Resonance, 7, pp. 823-825. (doi: 10.1080/10976640500295540)

Mark, P., Mazonakis, E., Rodger, R., Shapiro, D. and Spooner, R. (2005) Pseudohypocalaemia in an elderly patient with advanced renal failure and renovascular disease. Nephrology Dialysis Transplantation, 20, pp. 1499-1500. (doi: 10.1093/ndt/gfh836)

Mohamed, A., Thomson, J., McDonald, K., Hillyard, D., Mark, P., Elliott, H. and Jardine, A. (2005) Circulating endothelial cells in renal transplant recipients. Transplantation Proceedings, 37, pp. 2387-2390. (doi: 10.1016/j.transproceed.2005.03.126)

2004

Tutone, V.K., Mark, P.B. , Revanur, V., Traynor, J., Buist, L.J., Geddes, C.C., Deardon, D. and Jardine, A.G. (2004) Random blood glucose measurements and survival in nondiabetic renal transplant recipients. Transplantation Proceedings, 36(10), pp. 3006-3011. (doi: 10.1016/j.transproceed.2004.10.067)

Cowan, M., Dargie, H., Foster, J., Jardine, A., Johnston, N., Mark, P., Rodger, R. and Stewart, G. (2004) Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clinical Physiology and Functional Imaging, 24, pp. 387-393.

Articles

Harrison, L. L., Fu, E. L., Thomson, P. C., Traynor, J. P., Mark, P. B. and Stoumpos, S. (2024) Impact of arteriovenous fistula formation on trajectory of kidney function decline: a target trial emulation. Clinical Kidney Journal, (Accepted for Publication)

Lambourg, E. J. et al. (2024) Stopping versus continuing metformin in patients with advanced CKD: A nationwide Scottish target trial emulation study. American Journal of Kidney Diseases, (doi: 10.1053/j.ajkd.2024.08.012) (PMID:39521399) (In Press)

Rochmawati, I. D., Deo, S. , Lees, J. S. , Mark, P. B. , Sattar, N. , Celis-Morales, C. , Pell, J. P. , Welsh, P. and Ho, F. K. (2024) Adding traditional and emerging biomarkers for risk assessment in secondary prevention: a prospective cohort study of 20,656 patients with cardiovascular disease. European Journal of Preventive Cardiology, (doi: 10.1093/eurjpc/zwae352) (PMID:39474888) (Early Online Publication)

Walker, H., Sullivan, M. K. , Jani, B. D. , Mark, P. B. and Gallacher, K. I. (2024) Exploration of patients’ and health care professionals’ perspectives of kidney failure risk and the use of the kidney failure risk equation in MULTIPle lOng-term condItions aNd frailTy (MULTIPOINT) study: a qualitative interview and focus group study protocol. BMJ Open, 14(10), e085843. (doi: 10.1136/bmjopen-2024-085843) (PMID:39424379)

Walker, H., Day, S., Grant, C. H. , Jones, C., Ker, R., Sullivan, M. K. , Jani, B. D. , Gallacher, K. and Mark, P. B. (2024) Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review. BMC Medicine, 22, 452. (doi: 10.1186/s12916-024-03649-9) (PMID:39394084) (PMCID:PMC11470573)

Liu, Q., Celis-Morales, C. , Lees, J. S. , Sattar, N. , Ho, F., Pell, J. P. , Mark, P. B. and Welsh, P. (2024) Change in physical activity and its association with decline in kidney function: A UK Biobank-based cohort study. Journal of Cachexia, Sarcopenia and Muscle, 15(5), pp. 2046-2055. (doi: 10.1002/jcsm.13551) (PMID:39155482) (PMCID:PMC11446710)

Marshall, W. R., Curran, G. A., Traynor, J. P., Gillis, K. A. , Mark, P. B. and Lees, J. S. (2024) Sodium zirconium cyclosilicate treatment and rates of emergency interventions for hyperkalaemia: a propensity-score weighted case-control study. Clinical Kidney Journal, (doi: 10.1093/ckj/sfae313) (Accepted for Publication)

Elyan, B. M.P. , Sullivan, M. K. , Hedley, J., De La Mata, N., Webster, A. C., Venugopal, B., Jones, R. J. , Lang, N. N. , Mark, P. B. and Lees, J. S. (2024) The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis. BJC Reports, 2, 57. (doi: 10.1038/s44276-024-00081-7)

Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)

Lam, C. S.P. et al. (2024) Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial. European Journal of Heart Failure, 26(8), pp. 1727-1735. (doi: 10.1002/ejhf.3294) (PMID:38783712)

Madero, M., Chertow, G. M. and Mark, P. B. (2024) SGLT2 inhibitor use in chronic kidney disease: supporting cardiovascular, kidney, and metabolic health. Kidney Medicine, 6(8), 100851. (doi: 10.1016/j.xkme.2024.100851)

Sullivan, M. K. , Lees, J. S. , Rosales, B. M., Cutting, R., Wyld, M. L., Woodward, M., Webster, A. C., Mark, P. B. and De La Mata, N. (2024) Sex and the relationship between cardiometabolic risk factors and estimated GFR Decline: a population-based cohort study. American Journal of Kidney Diseases, (doi: 10.1053/j.ajkd.2024.05.007) (PMID:39053834) (In Press)

Collister, D. et al. (2024) Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae156) (Early Online Publication)

Zac-Varghese, S. et al. (2024) Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024. BMC Nephrology, 25(1), 216. (doi: 10.1186/s12882-024-03664-1) (PMID:38971750) (PMCID:PMC11227212)

Denicolò, S. et al. (2024) Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus. Diabetologia, 67(7), pp. 1283-1294. (doi: 10.1007/s00125-024-06149-w) (PMID:38647650) (PMCID:PMC11153278)

Denicolò, S. et al. (2024) Non-adherence to antidiabetic and cardiovascular medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus. Diabetologia, 67(7), pp. 1283-1294. (doi: 10.1007/s00125-024-06149-w) (PMID:38647650) (PMCID:PMC11153278)

Chertow, G. M. et al. (2024) Effects of dapagliflozin in patients with membranous nephropathy. Glomerular Diseases, 4(1), pp. 137-145. (doi: 10.1159/000539770) (PMID:39144475) (PMCID:PMC11324228)

Curtain, J. P. et al. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, 26(6), pp. 1383-1392. (doi: 10.1002/ejhf.3290) (PMID:38741283)

Loughrey, C. et al. (2024) A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic action: Pre-clinical and phase I study. British Journal of Pharmacology, 181(18), pp. 3401-3419. (doi: 10.1111/bph.16379) (PMID:38773354)

Stoumpos, S., van Rhijn, P., Mangion, K., Thomson, P. C. and Mark, P. B. (2024) Arteriovenous fistula for haemodialysis as a predictor of de novo heart failure in kidney transplant recipients. Clinical Kidney Journal, 17(5), sfae105. (doi: 10.1093/ckj/sfae105) (PMID:38737344) (PMCID:PMC11087827)

Del Vecchio, L. et al. (2024) Iron biology. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae095) (PMID:38658189) (Early Online Publication)

Rankin, S., Elyan, B. , Jones, R. , Venugopal, B., Mark, P. B. , Lees, J. S. , Petrie, M. C. and Lang, N. N. (2024) Cardiovascular eligibility criteria and adverse event reporting in combined immune checkpoint and VEGF inhibitors trials. JACC: CardioOncology, 6(2), pp. 267-279. (doi: 10.1016/j.jaccao.2023.12.010) (PMID:38774021) (PMCID:PMC11103039)

Chen, D. C. et al. (2024) Cystatin C- and creatinine-based estimated GFR differences: prevalence and predictors in the UK Biobank. Kidney Medicine, 6(4), 100796. (doi: 10.1016/j.xkme.2024.100796) (PMID:8567244) (PMCID:PMC10986041)

Heerspink, H. J.L. et al. (2024) Dapagliflozin and blood pressure in patients with chronic kidney disease and albuminuria. American Heart Journal, 270, pp. 125-135. (doi: 10.1016/j.ahj.2024.02.006) (PMID:38367893)

Shemilt, R. et al. (2024) Sex differences in cancer outcomes across the range of eGFR. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae059) (PMID:38460949) (Early Online Publication)

Adamson, W. E. et al. (2024) Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders. EBioMedicine, 101, 105000. (doi: 10.1016/j.ebiom.2024.105000) (PMID:38360481) (PMCID:PMC10944146)

Balafa, O., Fernandez-Fernandez, B., Ortiz, A., Dounousi, E., Ekart, R., Ferro, C. J., Mark, P. B. , Valdivielso, J. M., Del Vecchio, L. and Mallamaci, F. (2024) Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease. Clinical Kidney Journal, 17(3), sfae044. (doi: 10.1093/ckj/sfae044)

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)

Del Vecchio, L., Balafa, O., Dounousi, E., Ekart, R., Fernandez Fernandez, B., Mark, P. B. , Sarafidis, P., Valdivielso, J. M., Ferro, C. J. and Mallamaci, F. (2024) COVID-19 and cardiovascular disease: Additional risks for patients with chronic kidney disease. Nephrology Dialysis Transplantation, 39(2), pp. 177-189. (doi: 10.1093/ndt/gfad170) (PMID:37771078) (PMCID:PMC10828215)

Mayne, K. J. et al. (2023) Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease. Journal of the American Society of Nephrology, (doi: 10.1681/ASN.0000000000000271) (PMID:38082486) (Early Online Publication)

Andonovic, M., Curle, J., Traynor, J. P., Shaw, M., Sim, M. A.B., Mark, P. B. and Puxty, K. A. (2023) Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors. BJA Open, 8, 100243. (doi: 10.1016/j.bjao.2023.100243) (PMID:38143792) (PMCID:PMC10746363)

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7(4), pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Jani, B. D. , Sullivan, M. K. , Hanlon, P. , Nicholl, B. I. , Lees, J. S. , Brown, L., MacDonald, S. , Mark, P. B. , Mair, F. S. and Sullivan, F. M. (2023) Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role? British Journal of Cancer, (doi: 10.1038/s41416-023-02467-9) (PMID:37880510) (Early Online Publication)

Lees, J. S. and Mark, P. B. (2023) GFR slope as a surrogate marker for future kidney failure. Nature Reviews Nephrology, 19, pp. 625-626. (doi: 10.1038/s41581-023-00748-3) (PMID:37495682)

Lees, J. S. , De La Mata, N. L., Sullivan, M. K. , Wyld, M. L., Rosales, B. M., Cutting, R., Hedley, J. A., Rutherford, E., Mark, P. B. and Webster, A. C. (2023) Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding. European Stroke Journal, 8(3), pp. 756-768. (doi: 10.1177/23969873231173282)

Shemilt, R. et al. (2023) Sex differences in the diagnosis of advanced cancer and subsequent outcome in people with chronic kidney disease: an analysis of a national population cohort. medRxiv, (doi: 10.1101/2023.08.22.23294412)

Hull, K. L. et al. (2023) The NightLife study — the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial. Trials, 24(1), 522. (doi: 10.1186/s13063-023-07565-w) (PMID:37573352) (PMCID:PMC10422763)

Zhou, Z., Parra-Soto, S., Boonpor, J., Petermann-Rocha, F., Welsh, P. , Mark, P. B. , Sattar, N. , Pell, J. P. , Celis-Morales, C. and Ho, F. K. (2023) Exploring the underlying mechanisms linking adiposity and cardiovascular disease: a prospective cohort study of 404,332 UK Biobank participants. Current Problems in Cardiology, 48(8), 101715. (doi: 10.1016/j.cpcardiol.2023.101715) (PMID:37004891)

Elyan, B. M.P. , Rankin, S., Jones, R., Lang, N. N. , Mark, P. B. and Lees, J. S. (2023) Kidney disease patient representation in trials of combination therapy with VEGF-signaling pathway inhibitors and immune checkpoint inhibitors: a systematic review. Kidney Medicine, 5(7), 100672. (doi: 10.1016/j.xkme.2023.100672) (PMID:37492115) (PMCID:PMC10363559)

Lees, J. S. , Dobbin, S. J.H. , Elyan, B. M.P. , Gilmour, D. F., Tomlinson, L. P., Lang, N. N. and Mark, P. B. (2023) A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes. Nephrology Dialysis Transplantation, 38(7), pp. 1666-1681. (doi: 10.1093/ndt/gfac305) (PMID:36318455) (PMCID:PMC10310520)

O’Lone, E. et al. (2023) Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI expert working group. Kidney International, 103(6), pp. 1028-1037. (doi: 10.1016/j.kint.2023.02.033) (PMID:37023851)

Zoccali, C. et al. (2023) Cardiovascular complications in chronic kidney disease - a review from the European Renal and Cardiovascular Medicine Working Group (EURECA-m) of the European Renal Association (ERA). Cardiovascular Research, (doi: 10.1093/cvr/cvad083) (PMID:37249051) (Early Online Publication)

Mark, P. B. et al. (2023) SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease- a comprehensive review by EURECA-m and ERBP working groups of ERA. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfad112) (PMID:37230946) (Early Online Publication)

Lees, J. S. , Elyan, B. M.P., Hermann, S. M., Lang, N. N. , Jones, R. J. and Mark, P. B. (2023) The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrology Dialysis Transplantation, 38(5), pp. 1071-1079. (doi: 10.1093/ndt/gfac011) (PMID:35090037) (PMCID:PMC10157781)

Mark, P. B. et al. (2023) Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study. European Heart Journal, 44(13), pp. 1157-1166. (doi: 10.1093/eurheartj/ehac825) (PMID:36691956)

Mayne, K. J., Lees, J. S. and Mark, P. B. (2023) Cardiovascular complications of chronic kidney disease. Medicine, 51(3), pp. 190-195. (doi: 10.1016/j.mpmed.2022.12.008)

Mayne, K. J., Lees, J. S. , Rutherford, E., Thomson, P. C., Traynor, J. P., Dey, V. , Lang, N. N. and Mark, P. B. (2023) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort. Clinical Kidney Journal, 16(3), pp. 512-520. (doi: 10.1093/ckj/sfac248) (PMID:36865003) (PMCID:PMC9972818)

Chen, D. C., Lees, J. S. , Lu, K., Scherzer, R., Rutherford, E., Mark, P. B. , Kanaya, A. M., Shlipak, M. G. and Estrella, M. M. (2023) Differential associations of cystatin C versus creatinine‐based kidney function with risks of cardiovascular event and mortality among South Asian individuals in the UK Biobank. Journal of the American Heart Association, 12(3), e027079. (doi: 10.1161/JAHA.122.027079) (PMID:36695320) (PMCID:PMC9973614)

Sullivan, M. K. et al. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73(727), e141-e147. (doi: 10.3399/BJGP.2022.0145) (PMID:36376072) (PMCID:PMC9678375)

Surendrakumar, V. et al. (2023) Cardiorespiratory Optimisation By Arteriovenous fistula Ligation after renal Transplantation (COBALT): study protocol for a multicentre randomised interventional feasibility trial. BMJ Open, 13(2), e067668. (doi: 10.1136/bmjopen-2022-067668) (PMID:36759026) (PMCID:PMC9923321)

Bell, S. et al. (2023) The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland. Clinical Kidney Journal, 16(1), pp. 197-200. (doi: 10.1093/ckj/sfac173) (PMID:36721388) (PMCID:PMC9384465)

Ortiz, A. et al. (2023) Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. Nephrology Dialysis Transplantation, 38(1), pp. 10-25. (doi: 10.1093/ndt/gfab167) (PMID:33944938)

Petrie, M. C. et al. (2023) High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis. Cardiovascular Research, 119(1), pp. 213-220. (doi: 10.1093/cvr/cvab317) (PMID:34875022) (PMCID:PMC10022850)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)

Thöni, S. et al. (2023) International variability of renal and cardiovascular outcomes and mortality in patients with type 2 diabetes mellitus in Europe. Kidney and Blood Pressure Research, 48(1), pp. 165-174. (doi: 10.1159/000528438) (PMID:37015210) (PMCID:PMC10077442)

Lithgow, H. et al. (2022) Protocol for a randomised controlled trial to investigate the effects of vitamin K2 on recovery from muscle-damaging resistance exercise in young and older adults—the TAKEOVER study. Trials, 23, 1026. (doi: 10.1186/s13063-022-06937-y) (PMID:36539791) (PMCID:PMC9764575)

Mark, P. B. , Mangion, K., Rankin, A. J. , Rutherford, E., Lang, N. N. , Petrie, M. C. , Stoumpos, S. and Patel, R. K. (2022) Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients. Clinical Kidney Journal, 15(12), pp. 2186-2199. (doi: 10.1093/ckj/sfac146) (PMID:36381379) (PMCID:PMC9664574)

Mark, P. B. and Sattar, N. (2022) Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease. Lancet, 400(10365), pp. 1745-1747. (doi: 10.1016/S0140-6736(22)02164-X) (PMID:36351457)

Sullivan, M. K. et al. (2022) The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. BMC Medicine, 20, 420. (doi: 10.1186/s12916-022-02628-2) (PMID:36320059) (PMCID:PMC9623942)

Mayne, K. J., Shemilt, R., Keane, D. F., Lees, J. S. , Mark, P. B. and Herrington, W. G. (2022) Bioimpedance indices of fluid overload and cardiorenal outcomes in heart failure and chronic kidney disease: a systematic review. Journal of Cardiac Failure, 28(11), pp. 1628-1641. (doi: 10.1016/j.cardfail.2022.08.005) (PMID:36038013)

Lees, J. S. , Rutherford, E., Stevens, K. I., Chen, D. C., Scherzer, R., Estrella, M. M., Sullivan, M. K. , Ebert, N., Mark, P. B. and Shlipak, M. G. (2022) Assessment of Cystatin C level for risk stratification in adults with chronic kidney disease. JAMA Network Open, 5(10), e2238300. (doi: 10.1001/jamanetworkopen.2022.38300) (PMID:36282503) (PMCID:PMC9597396)

Sundström, J. et al. (2022) Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: the CaReMe CKD study. Lancet Regional Health - Europe, 20, 100438. (doi: 10.1016/j.lanepe.2022.100438) (PMID:36090671) (PMCID:PMC9459126)

Thomson, P. C. et al. (2022) An analysis of vascular access thrombosis events from the Proactive IV Iron Therapy in Hemodialysis Patients (PIVOTAL) trial. Kidney International Reports, 7(8), pp. 1793-1801. (doi: 10.1016/j.ekir.2022.05.008) (PMID:35967105) (PMCID:PMC9366296)

Lee, M. M.Y. et al. (2022) Effect of empagliflozin on kidney biochemical and imaging outcomes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation, 146(4), pp. 364-367. (doi: 10.1161/CIRCULATIONAHA.122.059851) (PMID:35877829)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)

Fard, A., Pearson, R., Lathan, R. , Mark, P. B. and Clancy, M. J. (2022) Perfusate composition and duration of ex-vivo normothermic perfusion in kidney transplantation: a systematic review. Transplant International, 35, 10236. (doi: 10.3389/ti.2022.10236) (PMID:35634582) (PMCID:PMC9130468)

Lees, J. , Rutherford, E., Stevens, K., Chen, D., Scherzer, R., Estrella, M., Sullivan, M. , Ebert, N., Mark, P. and Shlipak, M. (2022) FC077: Cystatin C testing improves risk stratification associated with chronic kidney disease without adopting age-adapted diagnostic thresholds : a UK Biobank Study. Nephrology Dialysis Transplantation, 37(Sup 3), I842-I843. (doi: 10.1093/ndt/gfac114.001)

Stevens, K., Delles, C. , Mark, P. , Thomson, P., Gill, J. , Gray, S. , Ho, F., Rutherford, E. and Lees, J. (2022) MO468: Moving more associates with reduced risk of cardiovascular disease and death across all stages of chronic kidney disease: a UK Biobank study. Nephrology Dialysis Transplantation, 37(Sup 3), i337. (doi: 10.1093/ndt/gfac070.082)

Sullivan, M. , Mark, P. , Mair, F. , Jani, B. , Nitsch, D. and Lees, J. (2022) FC079: The Race-Free EGFR Equation, the kidney failure risk equation and referrals to specialist renal clinics. Nephrology Dialysis Transplantation, 37(Sup 3), i844-i845. (doi: 10.1093/ndt/gfac114.003)

McQuarrie, E. P., Gillis, K. A. and Mark, P. B. (2022) Seven suggestions for successful SGLT2i use in glomerular disease – a standalone CKD therapy? Current Opinion in Nephrology and Hypertension, 31(3), pp. 272-277. (doi: 10.1097/MNH.0000000000000786) (PMID:35220316)

Sullivan, M. K. and Mark, P. B. (2022) Daprodustat in renal anaemia: changing the response to cellular hypoxia, but is it a game changer? Cardiovascular Research, 118(8), e54-e56. (doi: 10.1093/cvr/cvac067) (PMID:35639861)

Banerjee, D. et al. (2022) Management of hypertension in patients with diabetic kidney disease: summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021. Kidney International Reports, 7(4), pp. 681-687. (doi: 10.1016/j.ekir.2022.01.004) (PMID:35497783) (PMCID:PMC9039464)

Bell, S. et al. (2022) The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland. Journal of the American Society of Nephrology, 33(4), pp. 677-686. (doi: 10.1681/ASN.2022010046) (PMID:35110363)

Denicolò, S. et al. (2022) Clonal hematopoiesis of indeterminate potential and diabetic kidney disease: a nested case-control study. Kidney International Reports, 7(4), pp. 876-888. (doi: 10.1016/j.ekir.2022.01.1064) (PMID:35497780) (PMCID:PMC9039487)

Rankin, A. J. , Mayne, K., Allwood-Spiers, S., Hall Barrientos, P., Roditi, G., Gillis, K. A. and Mark, P. B. (2022) Will advances in functional renal magnetic resonance imaging translate to the nephrology clinic? Nephrology, 27(3), pp. 223-230. (doi: 10.1111/nep.13985) (PMID:34724286)

Andonovic, M., Traynor, J. P., Shaw, M., Sim, M. A.B., Mark, P. B. and Puxty, K. A. (2022) Short- and long-term outcomes of intensive care patients with acute kidney disease. EClinicalMedicine, 44, 101291. (doi: 10.1016/j.eclinm.2022.101291) (PMID:35198917) (PMCID:PMC8850318)

Lees, J. S. and Mark, P. B. (2022) Insights into vitamin K metabolism in chronic kidney disease: more complicated than kale deficiency. Kidney International, 101(2), pp. 216-219. (doi: 10.1016/j.kint.2021.11.022) (PMID:35065688)

Sullivan, M. K. et al. (2022) Acute kidney injury in patients hospitalised with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37(2), pp. 271-284. (doi: 10.1093/ndt/gfab303) (PMID:34661677) (PMCID:PMC8788218)

Banerjee, D. et al. (2022) Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021. BMC Nephrology, 23(1), 9. (doi: 10.1186/s12882-021-02587-5) (PMID:34979961) (PMCID:PMC8722287)

Lees, J. S. and Mark, P. B. (2022) Vitamin K supplementation and vascular health after kidney transplantation: authors' response. American Journal of Transplantation, 22(1), pp. 320-321. (doi: 10.1111/ajt.16769) (PMID:34291553)

Ralston, M. R., Stevenson, K. S., Mark, P. B. and Geddes, C. C. (2021) Clinical factors associated with severe hypophosphataemia after kidney transplant. BMC Nephrology, 22, 407. (doi: 10.1186/s12882-021-02624-3)

Crowe, K., Quinn, T. J. , Mark, P. B. and Findlay, M. D. (2021) “Is it removed during dialysis?”—cognitive dysfunction in advanced kidney failure—a review article. Frontiers in Neurology, 12, 787370. (doi: 10.3389/fneur.2021.787370)

Macfarlane, A. J.R. et al. (2021) Anaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) study protocol: a randomised controlled trial comparing primary unassisted patency at 1 year of primary arteriovenous fistulae created under regional compared to local anaesthesia. BMJ Open, 11(12), e052188. (doi: 10.1136/bmjopen-2021-052188) (PMID:34937718) (PMCID:PMC8704953)

Skopalik, S., Hall Barrientos, P., Matthews, J., Radjenovic, A. , Mark, P. , Roditi, G. and Paul, M. C. (2021) Image‐based computational fluid dynamics for estimating pressure drop and fractional flow reserve across iliac artery stenosis: a comparison with in‐vivo measurements. International Journal for Numerical Methods in Biomedical Engineering, 37(12), e3437. (doi: 10.1002/cnm.3437) (PMID:33449429)

Welsh, P. et al. (2021) Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions. European Journal of Preventive Cardiology, 28(18), pp. 1991-2000. (doi: 10.1093/eurjpc/zwaa063) (PMID:33624048)

Mark, P. B. et al. (2021) Stroke in hemodialysis patients randomized to different intravenous iron strategies: a prespecified analysis from the PIVOTAL trial. Kidney360, 2(11), pp. 1761-1769. (doi: 10.34067/KID.0004272021)

Sullivan, M. K. et al. (2021) Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings. BMC Medicine, 19, 278. (doi: 10.1186/s12916-021-02147-6)

Rankin, A. J. et al. (2021) Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal. Journal of Cardiovascular Magnetic Resonance, 23, 125. (doi: 10.1186/s12968-021-00822-4) (PMCID:PMC8580743)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print]. Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Sullivan, M. K. et al. (2021) Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clinical Kidney Journal, 14(11), pp. 2409-2419. (doi: 10.1093/ckj/sfab079) (PMCID:PMC8573008)

Lees, J. S. et al. (2021) The ViKTORIES trial: a randomised, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients. American Journal of Transplantation, 21(10), pp. 3356-3368. (doi: 10.1111/ajt.16566) (PMID:33742520)

Pearson, R., Geddes, C., Mark, P. , Clancy, M. and Asher, J. (2021) Transplantation of kidneys after normothermic perfusion: a single center experience. Clinical Transplantation, 35(10), e14431. (doi: 10.1111/ctr.14431) (PMID:34288129)

Rankin, A. J. et al. (2021) Global longitudinal strain by feature tracking cardiovascular MRI predicts mortality in patients with end stage kidney disease. Clinical Kidney Journal, 14(10), pp. 2187-2196. (doi: 10.1093/ckj/sfab020)

Touyz, R. M. et al. (2021) Cardiovascular and renal risk factors and complications associated with COVID-19. CJC Open, 3(10), pp. 1257-1272. (doi: 10.1016/j.cjco.2021.05.020) (PMID:34151246) (PMCID:PMC8205551)

Carr, E. J. et al. (2021) Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet, 398(10305), pp. 1038-1041. (doi: 10.1016/S0140-6736(21)01854-7) (PMID:34391504) (PMCID:PMC8360704)

Stoumpos, S. et al. (2021) Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function. Scientific Reports, 11, 18102. (doi: 10.1038/s41598-021-97625-5) (PMID:34518583) (PMCID:PMC8437985)

Boder, P., Mary, S. , Mark, P. B. , Leiper, J. , Dominiczak, A. F. , Padmanabhan, S. , Rampold, L. and Delles, C. (2021) Mechanistic interactions of uromodulin with the thick ascending limb: perspectives in physiology and hypertension. Journal of Hypertension, 39(8), pp. 1490-1504. (doi: 10.1097/HJH.0000000000002861) (PMID:34187999) (PMCID:PMC7611110)

Collister, D. et al. (2021) Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: a study within a trial. Contemporary Clinical Trials, 107, 106466. (doi: 10.1016/j.cct.2021.106466) (PMID:34098039)

Lees, J. S. et al. (2021) Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine, 38, 101030. (doi: 10.1016/j.eclinm.2021.101030) (PMID:34505030)

Jani, B. D. , Ho, F. K., Lowe, D. J. , Traynor, J. P., MacBride-Stewart, S. P., Mark, P. B. , Mair, F. S. and Pell, J. P. (2021) Comparison of COVID-19 outcomes among shielded and non-shielded populations. Scientific Reports, 11, 15278. (doi: 10.1038/s41598-021-94630-6) (PMID:34315958) (PMCID:PMC8316565)

Valdivielso, J. M., Balafa, O., Ekart, R., Ferro, C. J., Mallamaci, F., Mark, P. B. , Rossignol, P., Sarafidis, P., Del Vecchio, L. and Ortiz, A. (2021) Hyperkalemia in chronic kidney disease in the new era of kidney protection therapies. Drugs, (doi: 10.1007/s40265-021-01555-5) (PMID:34313978)

Jhund, P. S. et al. (2021) Heart failure hospitalization in adults receiving maintenance hemodialysis and effect of intravenous iron therapy: A report from PIVOTAL. JACC: Heart Failure, 9(7), pp. 518-527. (doi: 10.1016/j.jchf.2021.04.005) (PMID:34119470)

Kelly, D. M. et al. (2021) Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference. Stroke, 52(7), e328-e346. (doi: 10.1161/STROKEAHA.120.029680) (PMID:34078109)

Lees, J. S. , Mark, P. B. and Witham, M. D. (2021) Vitamin K and vascular calcification. Current Opinion in Nephrology and Hypertension, 30(4), pp. 430-436. (doi: 10.1097/MNH.0000000000000712) (PMID:33871429)

Li, K. K. et al. (2021) Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. Journal of Infection, 83(1), pp. 96-103. (doi: 10.1016/j.jinf.2021.04.020) (PMID:33895226) (PMCID:PMC8061788)

Edy, E. et al. (2021) Cardiovascular magnetic resonance for the detection of descending thoracic aorta calcification in patients with end-stage renal disease. Journal of Cardiovascular Magnetic Resonance, 23(1), 85. (doi: 10.1186/s12968-021-00769-6) (PMID:34162405) (PMCID:PMC8223384)

Chowdhury, T. A. et al. (2021) Association of british clinical diabetologists and renal association guidelines on the detection and management of diabetes post solid organ transplantation. Diabetic Medicine, 38(6), e14523. (doi: 10.1111/dme.14523) (PMID:33434362)

Lees, J. S. and Mark, P. B. (2021) Fruit for thought: lifestyle interventions to reduce the risk of future chronic kidney disease. Nephrology Dialysis Transplantation, 36(6), pp. 963-965. (doi: 10.1093/ndt/gfaa266) (PMID:33313844)

O’Sullivan, E. D., Lees, J. S. , Howie, K. L., Pugh, D., Gillis, K. A. , Traynor, J. P., Macintyre, I. and Mark, P. B. (2021) Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease. Nephrology, 26(4), pp. 328-332. (doi: 10.1111/nep.13844) (PMID:33368892)

Pearson, R., Asher, J., Jackson, A., Mark, P. B. , Shumeyko, V. and Clancy, M. J. (2021) Viability assessment and utilization of declined donor kidneys with rhabdomyolysis using ex vivo normothermic perfusion without preimplantation biopsy. American Journal of Transplantation, 21(3), pp. 1317-1321. (doi: 10.1111/ajt.16329) (PMID:33021059)

Lee, M. M.Y. et al. (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation, 143(6), pp. 516-525. (doi: 10.1161/CIRCULATIONAHA.120.052186) (PMID:33186500) (PMCID:PMC7864599)

Andonovic, M., Shemilt, R., Sim, M., Traynor, J. P., Shaw, M., Mark, P. B. and Puxty, K. A. (2021) Timing of renal replacement therapy for patients with acute kidney injury: a systematic review and meta-analysis. Journal of the Intensive Care Society, 22(1), pp. 67-77. (doi: 10.1177/1751143720901688) (PMID:33643435) (PMCID:PMC7890756)

Rankin, A. J. and Mark, P. B. (2021) Cardiac screening prior to renal transplantation – good intentions, rather than good evidence, dictate practice. Kidney International, 99(2), pp. 306-308. (doi: 10.1016/j.kint.2020.10.043) (PMID:33509350)

Lees, J. S. and Mark, P. B. (2021) Cystatin C to predict renal disease and cardiovascular risk. Nephrology Dialysis Transplantation, 36(1), pp. 39-41. (doi: 10.1093/ndt/gfaa152) (PMID:32514520)

Mark, P. B. , Del Vecchio, L., Valdivielso, J. M. and Malyszko, J. (2021) Same rhythm, different song - approaches to atrial fibrillation management by cardiologists and nephrologists. Clinical Kidney Journal, 14(1), pp. 9-13. (doi: 10.1093/ckj/sfaa146) (PMID:33564401) (PMCID:PMC7857826)

Rutherford, E. et al. (2021) A randomized, controlled trial of the effect of allopurinol on left ventricular mass index in hemodialysis patients. Kidney International Reports, 6(1), pp. 146-155. (doi: 10.1016/j.ekir.2020.10.025) (PMID:33358501) (PMCID:PMC7590839)

Dounousi, E., Tellis, C., Pavlakou, P., Duni, A., Liakopoulos, V., Mark, P. B. , Papagianni, A. and Tselepis, A. D. (2021) Association between PCSK9 levels and markers of inflammation, oxidative stress, and endothelial dysfunction in a population of nondialysis chronic kidney disease patients. Oxidative Medicine and Cellular Longevity, 2021, 6677012. (doi: 10.1155/2021/6677012) (PMID:34336112) (PMCID:PMC8318757)

Pearson, R., Murray, E. , Thomson, P. C., Mark, P. B. , Clancy, M. J. and Asher, J. (2021) The new UK national kidney allocation scheme with maximized “R4-D4” kidney transplants: better patient-to-graft longevity matching may be at the cost of more resources. Experimental and Clinical Transplantation, 19(11), pp. 1133-1141. (doi: 10.6002/ect.2021.0129) (PMID:34812704)

Kerschbaum, J. et al. (2020) Intra-individual variability of eGFR trajectories in early diabetic kidney disease and lack of performance of prognostic biomarkers. Scientific Reports, 10, 19743. (doi: 10.1038/s41598-020-76773-0) (PMID:33184434) (PMCID:PMC7665005)

Bell, S. et al. (2020) COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry. BMC Nephrology, 21, 419. (doi: 10.1186/s12882-020-02061-8) (PMID:33004002) (PMCID:PMC7528715)

Wheeler, D. C. et al. (2020) The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrology Dialysis Transplantation, 35(10), pp. 1700-1711. (doi: 10.1093/ndt/gfaa234) (PMID:32862232) (PMCID:PMC7538235)

Stoumpos, S., Tan, A., Hall Barrientos, P., Stevenson, K., Thomson, P., Kasthuri, R., Radjenovic, A. , Kingsmore, D., Roditi, G. and Mark, P. (2020) Ferumoxytol MR angiography vs Duplex ultrasound for vascular mapping before arteriovenous fistula surgery for hemodialysis. Radiology, 297(1), pp. 214-222. (doi: 10.1148/radiol.2020200069) (PMID:32692301)

Witham, M. D. et al. (2020) Vitamin K supplementation to improve vascular stiffness in chronic kidney disease: the K4Kidneys randomised controlled trial. Journal of the American Society of Nephrology, 31(10), pp. 2434-2445. (doi: 10.1681/ASN.2020020225) (PMID:32817311)

Cameron, A. C. et al. (2020) Comprehensive characterisation of the vascular effects of cisplatin-based chemotherapy in patients with testicular cancer. JACC: CardioOncology, 2(3), pp. 443-455. (doi: 10.1016/j.jaccao.2020.06.004) (PMID:33043304) (PMCID:PMC7539369)

Price, A. M. et al. (2020) Changes in blood pressure and arterial hemodynamics following living kidney donation. Clinical Journal of the American Society of Nephrology, 15(9), pp. 1330-1339. (doi: 10.2215/CJN.15651219) (PMID:32843374)

McQueenie, R. et al. (2020) Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS ONE, 15(8), e0238091. (doi: 10.1371/journal.pone.0238091) (PMID:32817712) (PMCID:PMC7440632)

Ferguson, A. C. et al. (2020) Alzheimer’s disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769). Journal of Alzheimer's Disease, 76(4), pp. 1541-1551. (doi: 10.3233/JAD-200338) (PMID:32651323)

Christakoudi, S. et al. (2020) Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy. EBioMedicine, 58, 102899. (doi: 10.1016/j.ebiom.2020.102899)

Stoumpos, S. et al. (2020) Ferumoxytol MR angiography: a novel technique for assessing iliac vasculature in potential kidney transplant recipients. JACC: Cardiovascular Imaging, 13(8), pp. 1847-1848. (doi: 10.1016/j.jcmg.2020.02.032) (PMID:32417328)

Lees, J. S. , Mangion, K., Rutherford, E., Witham, M. D., Woodward, R., Roditi, G., Hopkins, T., Brooksbank, K., Jardine, A. and Mark, P. B. (2020) Vitamin K for kidney transplant organ recipients: investigating vEssel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial. Open Heart, 7, e001070. (doi: 10.1136/openhrt-2019-001070) (PMID:32675297) (PMCID:PMC7368482)

Thaventhiran, J. E. D. et al. (2020) Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 583, pp. 90-95. (doi: 10.1038/s41586-020-2265-1) (PMID:32499645)

Sullivan, M. , Rankin, A. , Jani, B. D. , Mair, F. S. and Mark, P. B. (2020) Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. BMJ Open, 10, e038401. (doi: 10.1136/bmjopen-2020-038401) (PMID:32606067) (PMCID:PMC7328898)

Harhay, M. N. and Mark, P. B. (2020) Will universal access to health care mean equitable access to kidney transplantation? Clinical Journal of the American Society of Nephrology, 15(6), pp. 752-754. (doi: 10.2215/CJN.03000320) (PMID:32467308)

Macdougall, I. C. et al. (2020) Intravenous iron dosing and infection risk in patients on hemodialysis: a prespecified secondary analysis of the PIVOTAL trial. Journal of the American Society of Nephrology, 31(4), 2019090972. (doi: 10.1681/ASN.2019090972) (PMID:32253271)

Rankin, A. J. , Cannon, E., Gillis, K. , Crosby, J., Mark, P. B. , Geddes, C. C., Fox, J. G., Mackinnon, B., McQuarrie, E. and Kipgen, D. (2020) Predicting outcome in acute interstitial nephritis: a case series examining the importance of histological parameters. Histopathology, 76(5), pp. 698-706. (doi: 10.1111/his.14031) (PMID:31691330)

Hockings, P., Laustsen, C., Joles, J., Mark, P. and Sourbron, S. (2020) Special issue on magnetic resonance imaging biomarkers of renal disease. Magnetic Resonance Materials in Physics, Biology and Medicine, 33, pp. 1-2. (doi: 10.1007/s10334-019-00822-7) (PMID:31897904)

Rankin, A. J. et al. (2020) Comparing the interobserver reproducibility of different regions of interest on multi-parametric renal magnetic resonance imaging in healthy volunteers, patients with heart failure and renal transplant recipients. Magnetic Resonance Materials in Physics, Biology and Medicine, 33, pp. 103-112. (doi: 10.1007/s10334-019-00809-4) (PMID:31823275) (PMCID:PMC7021749)

Welsh, C. et al. (2020) Glycated hemoglobin, prediabetes and the links to cardiovascular disease: data from UK Biobank. Diabetes Care, 43(2), pp. 440-445. (doi: 10.2337/dc19-1683) (PMID:31852727)

Mark, P. B. , Papworth, R., Ramparsad, N., Tomlinson, L. A., Sahwney, S., Black, C., McConnachie, A. and McCowan, C. (2020) Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors. British Journal of Clinical Pharmacology, 86(1), pp. 121-131. (doi: 10.1111/bcp.14141) (PMID:31663151)

Mace-Brickman, T., Eddeen, A. B., Carrero, J.-J., Mark, P. B. , Molnar, A. O., Lam, N. N., Zimmerman, D., Harel, Z. and Sood, M. M. (2019) The risk of stroke and stroke type in patients with atrial fibrillation and chronic kidney disease. Canadian Journal of Kidney Health and Disease, 6, pp. 1-9. (doi: 10.1177/2054358119892372)

Kammer, M. et al. (2019) Integrative analysis of prognostic biomarkers derived from multiomics panels for the discrimination of chronic kidney disease trajectories in people with type 2 diabetes. Kidney International, 96(6), pp. 1381-1388. (doi: 10.1016/j.kint.2019.07.025) (PMID:31679767)

Williams, E. H. et al. (2019) Multicentre validation of the CamGFR model for estimated glomerular filtration rate. JNCI Cancer Spectrum, 3(4), pkz068. (doi: 10.1093/jncics/pkz068) (PMID:31750418) (PMCID:PMC6846361)

Grant, C. H. , Gillis, K. A. , Lees, J. S. , Traynor, J. P., Mark, P. B. and Stevens, K. I. (2019) Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis. QJM: An International Journal of Medicine, 112(11), pp. 835-840. (doi: 10.1093/qjmed/hcz166) (PMID:31251364)

Lees, J. S. et al. (2019) Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nature Medicine, 25, pp. 1753-1760. (doi: 10.1038/s41591-019-0627-8) (PMID:31700174) (PMCID:PMC6858876)

Welsh, C. et al. (2019) Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease: data from UK Biobank. Circulation, 140(7), pp. 542-552. (doi: 10.1161/CIRCULATIONAHA.119.041149) (PMID:31216866) (PMCID:PMC6693929)

Ha, J. T. et al. (2019) Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis. Annals of Internal Medicine, 171(3), pp. 181-189. (doi: 10.7326/M19-0087) (PMID:31307056)

Stapleton, C. P. et al. (2019) The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population. American Journal of Transplantation, 19(8), pp. 2262-2273. (doi: 10.1111/ajt.15326)

Welsh, C. E. , Welsh, P. , Jhund, P. , Sattar, N. and Mark, P. B. (2019) Response by Welsh et al to letter regarding article “Urinary sodium excretion, blood pressure, and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease”. Hypertension, 74, e27-e28. (doi: 10.1161/HYPERTENSIONAHA.119.13349) (PMID:31230548)

Neuberger, J., Armstrong, M. J., Fisher, J., Mark, P. , Schmidtke, K., Sharif, A. and Vlaev, I. (2019) Sport and exercise in improving outcomes after solid organ transplantation: overview from a UK meeting. Transplantation, 103(7S1), S1-S11. (PMID:31259878)

Stoumpos, S., Hennessy, M., Vesey, A. T., Radjenovic, A. , Kasthuri, R., Kingsmore, D. B., Mark, P. B. and Roditi, G. (2019) Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease. European Radiology, 29(7), pp. 3543-3552. (doi: 10.1007/s00330-019-06137-4) (PMID:30919067)

Green, D. et al. (2019) Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study. BMC Nephrology, 20(1), 220. (doi: 10.1186/s12882-019-1406-y) (PMID:31200662)

Clark, A. L., Kalra, P. R., Petrie, M. C. , Mark, P. B. , Tomlinson, L. A. and Tomson, C. R.V. (2019) Change in renal function associated with drug treatment in heart failure: national guidance. Heart, 105(12), pp. 904-910. (doi: 10.1136/heartjnl-2018-314158) (PMID:31118203) (PMCID:PMC6582720)

Lees, J.S. , Chapman, F.A., Witham, M.D., Jardine, A.G. and Mark, P.B. (2019) Vitamin K status, supplementation and vascular disease: a systematic review and meta-analysis. Heart, 105(12), pp. 938-945. (doi: 10.1136/heartjnl-2018-313955) (PMID:30514729)

Stoumpos, S. and Mark, P. B. (2019) Should we ligate arteriovenous fistulas in asymptomatic patients after kidney transplantation? Circulation, 139(25), pp. 2819-2821. (doi: 10.1161/CIRCULATIONAHA.119.040361) (PMID:31206325)

Stoumpos, S., Traynor, J. P., Metcalfe, W., Kasthuri, R., Stevenson, K., Mark, P. B. , Kingsmore, D. B. and Thomson, P. C. (2019) A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population. Journal of Vascular Surgery, 69(6), pp. 1889-1898. (doi: 10.1016/j.jvs.2018.10.063) (PMID:30583903)

Welsh, C. et al. (2019) Urinary sodium excretion, blood pressure and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease. Hypertension, 73, pp. 1202-1209. (doi: 10.1161/HYPERTENSIONAHA.119.12726) (PMID:31067194)

Stapleton, C. P. et al. (2019) Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort. American Journal of Transplantation, 19(3), pp. 801-810. (doi: 10.1111/ajt.15057) (PMID:30085400)

Gillis, K. A. , Lees, J. S. , Ralston, M. R., Glen, J. A., Stevenson, K. S., McManus, S. K., Geddes, C. C., Clancy, M., Traynor, J. P. and Mark, P. B. (2019) Interaction between socioeconomic deprivation and likelihood of pre‐emptive transplantation: influence of competing risks and referral characteristics – a retrospective study. Transplant International, 32(2), pp. 153-162. (doi: 10.1111/tri.13336) (PMID:30152890)

Eder, S. et al. (2019) Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries. Diabetes and Vascular Disease Research, 16(1), pp. 47-56. (doi: 10.1177/1479164118795559) (PMID:30238781)

Findlay, M. D., Dawson, J. , Dickie, D. A. , Forbes, K. P., McGlynn, D., Quinn, T. and Mark, P. B. (2019) Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients. Journal of the American Society of Nephrology, 30(10194), pp. 147-158. (doi: 10.1681/ASN.2018050462) (PMID:30530658) (PMCID:PMC6317612)

Lees, J.S. , Findlay, M.D., Mark, P.B. and Geddes, C.C. (2019) The impact of coronary angiography on renal transplant function. QJM: An International Journal of Medicine, 112(1), pp. 23-27. (doi: 10.1093/qjmed/hcy216) (PMID:30295913)

Findlay, M., Macisaac, R., MacLeod, M. J., Metcalfe, W., Sood, M. M., Traynor, J. P., Dawson, J. and Mark, P. B. (2019) The association of atrial fibrillation and ischaemic stroke in patients on haemodialysis: a competing risk analysis. Canadian Journal of Kidney Health and Disease, 6, pp. 1-13. (doi: 10.1177/2054358119878719) (PMID:31632680) (PMCID:PMC6767723)

Ferro, C. J. et al. (2018) Lipid management in patients with chronic kidney disease. Nature Reviews Nephrology, 14(12), pp. 727-749. (doi: 10.1038/s41581-018-0072-9) (PMID:30361677)

Christakoudi, S. et al. (2018) Steroid regulation: an overlooked aspect of tolerance and chronic rejection in kidney transplantation. Molecular and Cellular Endocrinology, 473, pp. 205-216. (doi: 10.1016/j.mce.2018.01.021) (PMID:29427591)

Findlay, M., MacIsaac, R., MacLeod, M. J., Metcalfe, W., Traynor, J. P., Dawson, J. and Mark, P. B. (2018) Renal replacement modality and stroke risk in end-stage renal disease—a national registry study. Nephrology Dialysis Transplantation, 33(9), pp. 1564-1571. (doi: 10.1093/ndt/gfx291) (PMID:29069522)

Findlay, M. D., Dawson, J. , MacIsaac, R., Jardine, A. G. , MacLeod, M. J., Metcalfe, W., Traynor, J. P. and Mark, P. B. (2018) Inequality in care and differences in outcome following stroke in people with end stage renal disease: results from a national registry linkage analysis. Kidney International Reports, 3(5), pp. 1064-1076. (doi: 10.1016/j.ekir.2018.04.011) (PMID:30197973) (PMCID:PMC6127409)

Kammer, M. et al. (2018) Validation of plasma biomarker candidates for the prediction of eGFR decline in patients with type 2 diabetes. Diabetes Care, 41(9), pp. 1947-1954. (doi: 10.2337/dc18-0532) (PMID:29980527) (PMCID:PMC6105325)

Selby, N. M. et al. (2018) Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA. Nephrology Dialysis Transplantation, 33(suppl2), ii4-ii14. (doi: 10.1093/ndt/gfy152) (PMID:30137584)

Gillis, K. , Stevens, K. K., Bell, E., Patel, R. K., Jardine, A. G. , Morris, S. T.W., Schneider, M. P., Delles, C. and Mark, P. B. (2018) Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease. Clinical Kidney Journal, 11(4), pp. 532-539. (doi: 10.1093/ckj/sfx158) (PMID:30094018) (PMCID:PMC6070083)

Welsh, P. et al. (2018) Circulating amino acids and the risk of macrovascular, microvascular, and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial. Diabetologia, 61(7), pp. 1581-1591. (doi: 10.1007/s00125-018-4619-x) (PMID:29728717) (PMCID:PMC6445481)

Hernandez-Fuentes, M. P. et al. (2018) Long‐ and short‐term outcomes in renal allografts with deceased donors: a large recipient and donor genome‐wide association study. American Journal of Transplantation, 18(6), pp. 1370-1379. (doi: 10.1111/ajt.14594) (PMID:29392897)

Welsh, C. et al. (2018) Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(6), pp. 1415-1423. (doi: 10.1161/ATVBAHA.118.310945) (PMID:29699973)

Evans, M. et al. (2018) Risk factors for prognosis in patients with severely decreased GFR. Kidney International Reports, 3(3), pp. 625-637. (doi: 10.1016/j.ekir.2018.01.002) (PMID:29854970) (PMCID:PMC5976849)

Mark, P. , Dekkers, I., Blankestijn, P., Leiner, T. and Roditi, G. (2018) Letter on 'European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis'. Journal of the European Academy of Dermatology and Venereology, 32(2), e84-e85. (doi: 10.1111/jdv.14774) (PMID:29283443)

Persu, A. et al. (2018) Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis. Journal of Hypertension, 36(2), pp. 221-229. (doi: 10.1097/HJH.0000000000001582) (PMID:29045339)

Stoumpos, S., Lees, J. , Welsh, P. , Hund, M., Geddes, C. C., Nelson, S. M. and Mark, P. B. (2018) The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation. Reproductive BioMedicine Online, 36(2), pp. 219-226. (doi: 10.1016/j.rbmo.2017.11.003) (PMID:29233504)

Taylor, A. H.M., Rankin, A. J. , McQuarrie, E. P., Freel, M., Homer, N. Z.M., Andrew, R., Jardine, A. G. and Mark, P. B. (2018) Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease. Clinical Science, 132(2), pp. 285-294. (doi: 10.1042/CS20171603) (PMID:29321218)

Mark, P. B. (2018) Strategies to manage cardiovascular risk in chronic kidney disease. Nephrology Dialysis Transplantation, 33(1), pp. 23-25. (doi: 10.1093/ndt/gfx329) (PMID:29237023)

Solbu, M. D., Mjøen, G., Mark, P. B. , Holdaas, H., Fellström, B., Schmieder, R. E., Zannad, F., Herrington, W. G. and Jardine, A. G. (2018) Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA Study. Nephrology Dialysis Transplantation, 33(1), pp. 102-112. (doi: 10.1093/ndt/gfw360) (PMID:27798199)

Mangion, K., McDowell, K., Mark, P. B. and Rutherford, E. (2018) Characterizing cardiac involvement in chronic kidney disease using CMR—a systematic review. Current Cardiovascular Imaging Reports, 11, 2. (doi: 10.1007/s12410-018-9441-9) (PMID:29497467) (PMCID:PMC5818546)

Stoumpos, S., Hennessy, M., Vesey, A. T., Radjenovic, A. , Kasthuri, R., Kingsmore, D. B., Mark, P. B. and Roditi, G. (2018) Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients. European Radiology, 28(1), pp. 115-123. (doi: 10.1007/s00330-017-4934-5) (PMID:28677065) (PMCID:PMC5717122)

Eder, S. et al. (2018) A prospective cohort study in patients with type 2 diabetes mellitus for validation of biomarkers (PROVALID) –study design and baseline characteristics. Kidney and Blood Pressure Research, 43(1), pp. 181-190. (doi: 10.1159/000487500)

Rutherford, E., Stewart, G., Houston, J. G., Jardine, A. G. , Mark, P. B. and Struthers, A. D. (2017) An open-label dose-finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients. Journal of Clinical Pharmacology, 57(11), pp. 1409-1414. (doi: 10.1002/jcph.939) (PMID:28597919)

Rutherford, E. et al. (2017) Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study. Scientific Reports, 7, 13976. (doi: 10.1038/s41598-017-14481-y) (PMID:29070834) (PMCID:PMC5656609)

Stevens, K., Denby, L., Patel, R. K., Mark, P. B. , Kettlewell, S., Smith, G. L. , Clancy, M. J., Delles, C. and Jardine, A. G. (2017) Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway. Nephrology Dialysis Transplantation, 32(10), pp. 1617-1627. (doi: 10.1093/ndt/gfw252) (PMID:27448672) (PMCID:PMC5837731)

Sanders, M. F. et al. (2017) Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography. European Radiology, 27(9), pp. 3934-3941. (doi: 10.1007/s00330-017-4770-7) (PMID:28271154)

Janowitz, T. et al. (2017) New model for estimating glomerular filtration rate in patients with cancer. Journal of Clinical Oncology, (doi: 10.1200/JCO.2017.72.7578) (PMID:28686534)

Findlay, M. D. and Mark, P. B. (2017) Reduced and declining physical function in prevalent dialysis patients – identifying the vulnerable. Age and Ageing, 46(4), pp. 541-543. (doi: 10.1093/ageing/afx049) (PMID:28407065)

Baker, R. J., Mark, P. B. , Patel, R. K., Stevens, K. K. and Palmer, N. (2017) Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrology, 18, 174. (doi: 10.1186/s12882-017-0553-2) (PMID:28571571) (PMCID:PMC5455080)

Ritchie, J. et al. (2017) Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation, 32(6), pp. 1006-1013. (doi: 10.1093/ndt/gfw107) (PMID:27257278)

Ptinopoulou, A. G., Pikilidou, M. I., Tziolas, I. M., Haidich, A.-B., Mark, P. B. , Zebekakis, P. E. and Lasaridis, A. N. (2017) Changes in kidney function in a population with essential hypertension in real life settings. Iranian Journal of Kidney Disease, 11(3), pp. 192-200. (PMID:28575879)

Sarafidis, P. A. et al. (2017) Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Journal of Hypertension, 35(4), pp. 657-676. (doi: 10.1097/HJH.0000000000001283) (PMID:28157814)

Sarafidis, P. A. et al. (2017) Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrology Dialysis Transplantation, 32(4), pp. 620-640. (doi: 10.1093/ndt/gfw433) (PMID:28340239)

Dawson, J. and Mark, P. B. (2017) Uric acid and decline in renal function-partners in crime. American Journal of Nephrology, 45(4), pp. 327-329. (doi: 10.1159/000464261) (PMID:28285315)